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4.1    A model describing the effect of Aebp2 heterozygousity on the PRC2  













AEBP2 is a zinc finger protein that has been shown to interact with the mammalian 
Polycomb Repression Complex 2 (PRC2).  I characterized this unknown protein and 
tested its potential targeting roles for the PRC2.  AEBP2 is an evolutionarily well-
conserved gene that is found in animals ranging from flying insects to mammals.  The 
transcription of mammalian AEBP2 is driven by two alternative promoters and produces 
multiple transcripts that give rise to at least two isoforms of the protein.  These isoforms 
show developmental stage-specific expression patterns: the larger adult-specific form (52 
kDa) and the smaller embryo-specific form (31 kDa).  The AEBP2 protein binds to a 
DNA-binding motif with an unusual bipartite structure, CTT(N)15-23cagGCC with 
lower-case base pairs being less critical.  A large fraction of AEBP2's target loci also map 
closely to the known target loci of the PRC2.  In fact, many of these loci are co-occupied 
by the two proteins, AEBP2 and SUZ12.  This suggests that AEBP2 is most likely a 
targeting protein for the mammalian PRC2 complex.  To investigate the in vivo roles of 
this protein, a mutant mouse line with disrupted Aebp2 transcription has been generated.  
Breeding experiments demonstrated embryonic lethality in the Aebp2-mutant 
homozygotes, but survival of the heterozygotes to adulthood with fertility.  In developing 
mouse embryos, Aebp2 is expressed mainly within cells of neural crest origin, such as the 
dorsal root ganglia, and facial cartilages and bones.  In addition, many heterozygotes 
display a set of phenotypes, including enlarged colon and hypopigmentation, similar to 
those observed in human patients with Hirschsprung’s disease and Waardenburg 
syndrome.  These phenotypes are caused by the absence of the neural crest-derived 
ganglia in hindguts and melanocytes.  Additional analyses further confirmed changes in 
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the expression and methylation levels of H3K27me3 on the genes involved in the 
development of the neural crest cells in the Aebp2 heterozygotes.  Overall, these results 
suggest that Aebp2 may regulate the development of the neural crest cells through the 









































































The Evolution of Genetic Studies: Classical Genetics, Genomics, and Reverse 
Genetics 
 
Gregor J. Mendel introduced the concept of “factors,” as units of information that are 
passed on to the next generation.  He claimed that these factors, which exist in pairs, give rise to 
phenotypic traits.  In addition, he discovered that these factors segregate independently 
(independent assortment) during reproduction (Mendel, 1865).  His “factors” are now known as 
genes, and the scientific community often refers to Mendel’s law of inheritance to explain how 
the phenotype of offspring arises from the parental genotype.  
In classical genetic studies, a mutant phenotype is observed and the genes or alleles 
responsible for that phenotype are determined by genetically mapping them through genetic 
crosses.  Many genes important in the development of organisms have been identified through 
these genetic studies.  We now know that the human genome contains approximately 25,000 
genes (Stein, 2004).  It would be challenging to characterize all of these genes solely by classical 
genetic studies, since not all genes correlate with obvious phenotypes, and because there are 
resolution limits to genetic mapping by genetic crosses.  Thus, great effort has been made to 
sequence the genomes of human, flies, mouse, and yeast.  With recent advances in DNA 
sequencing technologies, hundreds of organisms have been mapped and sequenced.  The glut of 
data generated from whole-genome sequencing has given us new approaches in studying 
genetics, and a new field called “genomics” has arisen as a powerful way of analyzing genes and 
regulatory regions in a genome.  A gene’s presence in a multitude of organisms can demonstrate 
that it is highly conserved rather than specific to a particular lineage of animals.  In addition, site 
directed mutagenesis, recombination techniques, and RNA interference can be used to remove or 
silence a particular gene of interest or to alter their conserved regulatory regions.  Some genetic 
alterations lead to the discovery of a new mutant phenotype and reveal the function of that 
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particular gene.  This genetic approach, in which we select a particular gene and then unearth its 
phenotype, is called “reverse genetics” (Takahashi et al., 1994).  We applied a reverse genetic 
approach to examine the gene function of Aebp2 (adipocyte enhancer binding protein 2): first by 
utilizing the whole genome sequence for evolutionary conservation studies, and second by 
generating Aebp2 mutant mice lines. These studies unraveled the evolutionary conservation of 
Aebp2; exons in the gene that may encode critical protein domains; and potential function of this 
protein.  
Epigenetics 
After fertilization, the zygote divides continuously to develop into a full body.  In this 
sense, we are derived from a single cell, and presumably each and every cell in our body (except 
our germ cells and some immune cells) contains the same genome.  However, our liver cells are 
clearly different from our brain cells.  The human body is composed of at least 200 different cell 
types.  How then do these different cell types arise from a single genome?  In 1950, Conrad 
Waddington coined the term “epigenetics” to explain from an organism’s developmental 
perspective that different cells arise due to the influence of different environments (van 
Speybroeck, 2002).  Recently, this definition of epigenetics has expanded due to the 
accumulation of various epigenomes observed among different cells and individuals (Feinberg, 
2010).  Studies suggest that different cell types arise from tissue-specific expression of certain 
genes in a spatial and temporal manner and that gene regulation occurs at multiple cellular levels.  
In addition, through mitosis, these cell-specific patterns of gene expression can be passed onto 
the next generation of daughter cells.  This type of genetic inheritance, which is independent of 
the DNA sequence, is a component of the modern definition of “epigenetics” (Haig, 2004).  
Epigenetics can be used to understand the different phenotypic outcomes observed between two 
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individuals with the same genotypes, for example, monozygotic twins.  Despite identical genetic 
makeup, twins may demonstrate variations in height, weight, personalities, and even cancer 
susceptibilities (Petronis et al., 2006; Fraga et al., 2005).  Thus, we suspect that epigenetic 
inheritance patterns are susceptible to changes in environmental conditions.  In addition, 
epigenetic marks are reversible; unlike our DNA sequence, which is relatively fixed (Handel et 
al., 2010).  Another perception that broadened Waddington’s definition of “epigenetics” is the 
theory of epigenetic inheritance through meiosis.  Some epigenetic marks can be passed on to the 
next generation through our germ cells.  This phenomenon is called “transgenerational epigenetic 
inheritance” (Youngson and Whitelaw, 2008).  For example, studies in mice show that the 
mother’s nutritional intake of methyl donor supplement throughout pregnancy could give rise to 
variable coat colors in their offspring and also in their offspring’s next generation (Cropley et al., 
2006; Morgan and Whitelaw, 2008).  In addition, from human case studies, two families with 
colorectal cancer showed abnormal epigenetic marks in a tumor suppressor gene (MLH1), which 
was inherited from their mother’s germ cells (Hitchins et al., 2007).   Although the field of 
transgenerational epigenetic inheritance is relatively new, these studies have brought new insight 
on the importance of environmental exposure, e.g. diet, and its effect on our developing 
offspring.  The plasticity of epigenetic inheritance is of vital practical importance.  
Understanding the mechanisms of environmental effects on epigenetic marks may lead to new 
approaches to disease prevention, cancer treatment, and regenerative medicine. 
Epigenetic Mechanisms: DNA Methylation and Histone Modifications 
Four epigenetic mechanisms for gene regulation have been suggested so far:  DNA 
methylation, histone modification, RNA interference, and chromatin structure.  Of these 
mechanisms, DNA methylation is the most studied and biochemically well understood epigenetic 
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mechanism (Feinberg, 2010).  DNA methylation occurs by the attachment of a methyl group 
(CH3) to a cytosine base that immediately follows a guanine base (CpG).  Some of the most 
important enzymes responsible for DNA methylation are DNA methyltransferase1 (DNMT1) 
and DNA methyltransferase3 (DNMT3).  DNMT3a and DNMT3b are important for de novo 
methylation (Okano et al., 1999) and DNMT1 is important for DNA methylation maintenance by 
methylating hemi-methylated DNA (Sharif et al., 2007).  Several theories have been suggested to 
explain the mechanistic role of DNA methylation.  Many agree that DNA methylation can block 
certain transcription factors from binding to regulatory regions.  Some suggest that DNA 
methylation may have an important role in chromatin structure (Weber and Schubeler, 2007).  
Although the molecular functions of DNA methylation are in the process of being discovered, 
the importance of DNA methylation for the survival of an organism is well known.  For example, 
in eukaryotic organisms, many of the repetitive elements in the genome are silenced by DNA 
methylation, and loss of these methyl marks lead to ectopic expression of nearby genes and 
instability of transposable elements (Bird, 2002; Cedar and Bergman, 2009).  Notably, mutations 
in the DNMT3b gene are often found in human patients with ICF (immunodeficiency, 
centromeric instability, facial anomalies) syndrome (Wijmenga et al., 1998).  DNA methylation 
is also important for proper genomic imprinting in mammals (Li et al., 1993).  Genomic 
imprinting is a process in which one specified parental allele is expressed.  Many imprinted 
genes maintain their imprinted status through DNA methylation.  For example, Peg3 is a 
paternally expressed imprinted gene (!"#$%&' et al., 1996; Relaix et al., 1998).  The promoter 
region of the maternal allele of Peg3 is heavily methylated and repressed while the promoter 
region of the paternal allele is unmethylated and expressed.  This methylation pattern has to be 
maintained throughout cell divisions to maintain the proper expression level of this gene in 
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somatic cells.  In humans, hypermethylation in the regulatory region of the paternal allele of 
PEG3 has been observed in patients with ovarian cancer (Feng et al., 2008).       
Histone modification is another epigenetic mechanism that is beginning to assert its 
importance in the epigenetic field.  Thomas Jenuwein, David Allis, and Bryan Turner first 
announced the “histone code” hypothesis in 2001.  They claimed that histone tails are modified 
and that these modifications indicate the active or repressed state of the associated gene (Turner 
2000; Jenuwein and Allis, 2001).  There are debates over the details of this theory, but recent 
studies seem to indicate that it is in part true.  Innovative molecular techniques such as chromatin 
immunoprecipitation (ChIP) assay followed by DNA sequencing (ChIP-seq) have allowed us to 
determine the different histone modification patterns for many genes.  An overview of modern 
ChIP-seq is demonstrated in Figure 1.1.  
Various histone modification marks have been discovered, however the two most studied 
histone marks are histone acetylation and histone methylation.  Histone acetylation is generally 
associated with gene expression while histone deacetylation is generally associated with gene 
repression.  The transcriptional regulatory role of histone methylation is more complex than 
histone acetylation; i.e. transcriptional regulatory outcome of histone methylation is dependent 
on the location of the lysine that is methylated.   H3K4me3 (histone H3 lysine 4 trimethylation) 
is associated with active genes while H3K9me3 and H3K27me3 are associated with repressed 
genes.   
Accumulation of the ChIP-seq (and also ChIP-array) data of these modified histones has 
provided a superior view of the histone marks in different tissues.  For example, an overview of 




Figure 1.1. Global ChIP-sequencing.  Proteins bound to DNA are crosslinked by 
formaldehyde.  The red boxes represent genes and the blue and yellow symbols represent 
proteins (e.g. modified histone marks).  Sonication fragments the DNA into shorter fragments, 
and primary antibodies are added to select for DNA that is bound by a protein of interest (in this 
figure the primary antibody selects for the protein in blue).  Agarose beads attach to the primary 
antibody and precipitate the antibody-protein-DNA complex (agarose beads are indicated in 
grey).  The precipitated complex is decrosslinked and DNA is isolated.  These DNA fragments 
are further amplified by PCR, sequenced, and mapped onto the genome.  Based on the 
enrichment of the DNA fragment, the protein-DNA interaction can be estimated (in the figure 
above, the blue protein preferably binds the left side of the first gene than in between the two 




Figure 1.2.  An overview of histone modification marks on the Aebp2 gene in embryonic 
stem cells.  The UCSC genome browser (http://genome.ucsc.edu/) is utilized to view multiple 
histone modification marks on a specific loci in a certain cell type.  In this example, the Aebp2 
gene in mouse is shown on top in purple (multiple lines indicate alternative transcripts).  The 
arrows in the gene indicate the direction of transcription.  The peaks indicated below the gene 
represent the enrichment of the modified histone marks on the corresponding region.  The Aebp2 
gene shows enrichment of histone methylation in H3K4 (in green) and H3K36me3 (in blue), and 
scarce levels of H3K27me3 (in red) and H3K9me3 (in brown). 
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These studies suggest that the modified histones each exhibit distinct patterns of enrichment that 
varies depending on the tissue type, the associated gene, and the preferable enrichment site in the 
regulatory regions of the gene (Bernstein et al., 2006; Barski et al., 2007).  Thus, obtaining a 
global map of these modified histone marks in various tissues should help us understand the 
epigenetic signatures in different cell types. 
Epigenetic Modifier: Polycomb Group Proteins 
As much as there has been emphasis to gain a global overview of various histone marks, 
much effort has also been made to find the key modifiers of these histones.  Polycomb group 
proteins (PcG) are of great interest due to their potential role as epigenetic modifiers.  These 
genes were first identified in Drosophila that contained extra sex combs in their legs (Lewis, 
1978), hence the name, “polycomb.”  Mammalian studies of the polycomb complex showed that 
they are important in regulating developmental genes such as Hox genes (van der Lugt et al., 
1994; Core et al., 1997).  The protein complex is composed of two complexes:  polycomb 
repressive complex 1 and 2 (PRC1 and PRC2, respectively).  PRC2 contains a histone 
methyltransferase, Ezh2, which tri-methylates histone H3 lysine 27 (H3K27me3), while PRC1 
contains a ubiquitin ligase, RING1, that ubiquitinates histone H2A lysine 119 (H2AK119ub1) 
(Cao and Zhang, 2004; de Napoles et al., 2004).  Due to their enzymatic activities of modifying 
histones, PcG proteins are considered epigenetic modifiers.  The role of the polycomb complex 
in cell lineage determination has been controversial. Many PcG proteins bind to developmental 
regulator genes in stem cells.  As a result, it was assumed that PcG proteins would play an 
important role in maintaining the pluripotent state of stem cells (Bernstein et al., 2006; Valk-
Lingbeek et al., 2004).  However, recent studies have shown that the PcG proteins could be 
dispensable for stem cell maintenance (Kerppola, 2009; Chamberlain et al., 2008).  Now, PcG 
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proteins are thought to play a regulatory role in cell lineage determination by binding to 
developmental genes and preparing them to differentiate according to their environmental signals 
(Rando and Chang, 2009).  Many of the PcG target gene expressions are also altered in cancer 
cells (Baylin, 2009).  Hence, much interest in understanding the role of PcG proteins also exists 
in the field of cancer biology. 
Despite the global role of PcG proteins in regulating developmental genes, how PcG 
proteins are targeted to specific DNA sequences is unclear; especially since none of the core 
mammalian PcG proteins bind to DNA.  Some studies have suggested that noncoding RNA 
could regulate PcG target specificity (Rinn et al., 2007; Zhao et al., 2008), however, further 
studies are required to demonstrate if the experimental outcome is a direct or indirect effect.   
In addition to regulatory RNAs, transcription factors that target the PcG proteins to DNA 
likely exist.  In flies, the transcription factor Pho is known as the PRC2 targeting protein.  As a 
result, the mammalian homolog YY1 has been suggested as the mammalian targeting protein for 
PRC2 (Atchison et al., 2003).  However, the direct interaction between YY1 and the PRC2 
complex has never been demonstrated.  Unfortunately, the transcription factors that associate 
with the PcG proteins have not yet been discovered in mammals.  Thus, indentifying and 
characterizing transcription factors that associate with the PcG proteins would allow better 
understanding of the functional role of PcG proteins and their target specificity.   
Recent biochemical protein purification studies of the PRC2 complex showed that 
AEBP2 interacts with PRC2 (Cao and Zhang, 2004; Peng et al., 2009; Shen et al., 2009; Li et al., 
2010; Pasini et al., 2010).  AEBP2 was first identified as a zinc finger protein, which bound to 
the enhancer of adipose P2 gene and had transcriptional repressor activity (He et al., 1999).  Our 
studies suggest that AEBP2 could be a potential transcription factor responsible for targeting 
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PRC2 complex to DNA in mammals.  Experimental data that supports our theory are illustrated 
in chapters two and three. 
Transcription Factors 
In bacteria, 98% of the genome encodes for proteins, while in eukaryotic organisms like 
humans, protein-coding genes comprise only 1.5% of the genome.  As we evolved to become a 
multicellular organism, proper gene regulation has become critical for our development.  Our 
genes contain many regulatory elements, such as promoters, enhancers and insulators, which 
regulate gene transcription.  These regulatory elements are often bound by transcription factors.  
RNA polymerase II, which is required for transcription, binds to promoters near transcriptional.  
However, RNA polymerase alone cannot bind to naked DNA, hence basal transcription factors 
are required for the RNA polymerase to bind DNA (Buratowski et al., 1989; Sopta et al., 1989).  
Different genes have different transcription factor binding sites, and their associated transcription 
factors are expressed in a highly restricted manner.  Most transcription factors bind DNA and 
activate or suppress transcription of target genes (Struhl, 1995).  In addition, they can also 
modulate the activity of gene expression by interacting with other factors (Brivanlou and 
Darnell, 2002).  Transcription factors are likely among the main components for determining 
proper cell differentiation and lineage commitment.  The significant roles of transcription factors 
in lineage determination can be appreciated from the recent discovery that four transcription 
factors, Oct4, Sox2, c-Myc and Klf4, can induce somatic cells to be reprogrammed back into 
pluripotent stem cells (Takahaski and Yamanaka, 2006).  This area of research is very promising 
for future medicine, because it may be possible to generate personalized cells or tissues such as 
insulin secreting cells (islets) or nerve cells from patient’s own somatic cells to treat their chronic 
illnesses. 
 12 
 According to our studies, Aebp2 is an important transcription factor that could facilitate 
cell lineage commitment through PRC2.  Thus, we examined the DNA binding properties of 
Aebp2 as well as its expression patterns.  Our results revealed that Aebp2 indeed binds DNA and 
that high expression levels of Aebp2 are found in the neural crest cells during embryonic 
development.  This suggests that Aebp2 is an important transcription factor required for neural 
crest cell development. 
Neural Crest Cells 
Neural crest cells were discovered by the embryologist Wilhelm His.  From an evolutionary 
perspective, neural crest cells exist among land vertebrates and are thought to have evolved in 
the vertebrate lineage to help the animals adopt a predatory lifestyle (Gans, 1983; Northcutt, 
2005).  Neural crest cells are generated between the epidermis and the neural plate of the 
developing embryo (Vogt, 1925).   This cell population arises from the ectoderm, and contains 
the capability to be multipotent and to migrate throughout the developing body (Le Douarin and 
Kalcheim, 1999).  Neural crest cells give rise to many different cell types such as melanocytes, 
adrenal glands, cranial facial bone, and cells in the peripheral nervous and enteric nervous 
systems (Le Douarin and Kalcheim, 1999).  Due to their significant functions in vertebrate 
animals, neural crest cells are often referred to as the ‘fourth germ layer’ (Hall, 2000).  
Numerous studies have suggested stem-cell properties of this cell lineage (Strobl-Mazzulla et al., 
2010).  In addition, some suggest that a small population of neural crest cells contain neural crest 
stem cells (NCSC) (Strobl-Mazzulla et al., 2010, Shakhova and Sommer, 2010; Stemple and 
Anderson, 1992).  Depending on the distribution of the neural crest cells, they are divided into 
five types: cranial, cardiac, trunk, vagal and sacral.  Fluorescent labeling studies show that these 
four neural crest cell types have distinct migration pathways and preferential cell derivatives.  
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For example, cranial neural crest cells give rise to the facial cartilage and bone structures, cardiac 
neural crest cells give rise to the septum between the aorta and pulmonary artery, trunk neural 
crest cells give rise to the dorsal root ganglion, and vagal and sacral neural crest cells give rise to 
the enteric nervous system.  Improper migration or differentiation of neural crest cells can lead to 
various genetic disorders, such as Hirschsprung’s disease.  Hirschsprung’s disease is 
characterized by missing ganglion cells in the intestine, which result in aperistalsis in the colon.  
This is a genetic disorder caused by improper development of vagal neural crest cells in the 
colon (McCallion et al., 2003; Amiel et al., 2008; Tam and Garcia-Barcelo, 2009). 
Several transcription factors have been determined to be important in proper neural crest 
cell development and migration.  Since neural crest cells are a delicate cell population (having to 
properly maintain a stem cell-like state before lineage commitment, migrate, and differentiate 
into the proper cell type when expected) it is important to understand how neural crest cell 
development is regulated by various transcription factors.  Transcription factors such as SOX10, 
BMP4, and MITF are evolutionarily well-conserved among vertebrates and are thought to be 
important factors for neural crest cell development.  However, studies suggest that the regulatory 
role of these transcription factors may vary among animals.  For example, variable results were 
observed amongst different organisms when Bmp4 was overexpressed in the primary stage of 
generating neural crest cells.  Overexpression of Bmp4 in frogs induced the epidermis (Wilson et 
al., 1997), while overexpression of Bmp4 in amniotes, such as mice and chickens, had no effect 
(Streit et al., 1998).  Despite these variations, other experimental observations suggest that the 
fundamental mechanism in regulating neural crest cell development should be conserved 
(LaBonne and Bronner-Fraser, 1999).  Cells extracted from the Hensen’s node of chick embryos 
were able to induce neural tissue in frogs (Kintner and Dodd, 1991).  Also, mutations in the 
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SOX10 gene result in aganglionic colon phenotypes in both humans and mice (Pingault et al., 
1998; Southard-Smith et al., 1998).  This suggests that neural crest cells from different species 
share fundamental transcription factors that fulfill common roles.  Consequently, the variable 
outcome of Bmp4 may have been due to the availability of different protein interaction partners.  
In addition, there could be some differences in the epigenetic marks between the two organisms.  
The epigenetic studies in neural crest cells are almost “untouched” (Nelms and Labosky, 2010).  
Therefore, further studies to reveal other transcription factors and epigenetic modifiers that could 
participate in the development of neural crest cells are necessary. 
The following studies in Aebp2 mutant mice suggest that Aebp2 is an important 
transcription factor for proper neural crest cell development.  Since we suspect that Aebp2 may 
play a role in epigenetic modifications, our findings should contribute to the understanding of 
how neural crest cells commit to their cell fate through epigenetic modification. 
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AEBP2 is a Gli-type zinc finger protein, which was originally identified due to its in vitro 
binding capability to the promoter region of adipose P2 (aP2) gene encoding a fatty acid-binding 
protein (He et al., 1999). This initial study revealed that this protein contains three zinc finger 
units and a novel basic domain, and also that this protein may function as a repressor based on 
co-transfection reporter assays. Soon afterwards, the homologous protein, called JING (meaning 
‘still’), was also isolated from Drosophila (Liu and Montell, 2001). According to the results from 
several studies, JING is involved in border cell migration (Liu and Montell, 2001) and 
development of the central nervous system (Sedaghat et al., 2002). Genetic studies further 
suggested that jing may interact with the fly Polycomb Group (PcG) protein complexes (Culi et 
al., 2006; McClure and Schubiger, 2008). The potential role of AEBP2 as a component of the 
PcG complexes has been further strengthened by another series of studies using the mammalian 
cell line system (Cao et al., 2002). Human AEBP2 has been co-purified with the mammalian 
PcG Repression Complex 2 (PRC2), and the subsequent study revealed that the AEBP2 protein 
can interact with the three core components of PRC2, including EED, SUZ12 and RbAp48, and 
that the interaction of AEBP2 with these proteins enhances the catalytic activity of the histone 
methylation activity of the PRC2 complex (Cao and Zhang, 2004).  
Although the core proteins for PRC2 have been identified, the mechanism by which 
PRC2 is targeted to numerous genomic loci is currently unknown (Kohler and Villar, 2008). This 
lack of knowledge is mainly due to the facts that the identified core proteins do not have DNA-
binding capability, and that DNA-binding proteins have never been consistently co-purified with 
the PRC2 (Cao and Zhang, 2004; Ringose and Paro, 2004 Muller and Kassis, 2006; Schwartz 
and Pirrotta, 2008). In Drosophila, however, another Gli-type zinc finger gene, called pho 
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(Pleiohomeotic), has been shown to be a targeting protein for its PcG complexes (Brown et al., 
1998). Recent studies further confirmed the presence of two Pho-containing complexes, INO80 
and PhoRC, and PhoRC is now regarded as a new member of PcG complexes based on its 
repression role through another PcG protein, SFMBT [Sex comb on middle leg-related gene with 
four mbt domains; (Klymenko et al., 2006)]. Along with the other data from several studies, this 
evidence has long suggested that YY1 (Yin Yang 1), the mammalian homologue of pho, might 
be a targeting protein for the mammalian PRC2. Nevertheless, this possibility has not been 
formally demonstrated so far. In that regard, it is intriguing to point out that AEBP2 has both 
DNA-binding capability and PcG connection. Thus, it has been hypothesized that AEBP2 might 
be a targeting protein for the mammalian PRC2. However, very little is known about the general 
aspects of AEBP2, in particular its DNA-binding motif and downstream genes.  
As part of the effort of characterizing this largely unknown gene and to test the above 
possibility, we have conducted a series of comparative genomics and DNA-binding motif studies 
in the current study. According to the results derived from this study, AEBP2 is an evolutionarily 
well-conserved protein that is found in all the animals ranging from flying insects to placental 
mammals. The exon structure of mouse Aebp2 indicates the presence of alternative splicing 
involving both 5"- and 3"-end exons, and subsequently two major forms of AEBP2 with different 
protein sizes, 52 and 31 kDa. A series of ChIP cloning experiments using anti-AEBP2 and -
SUZ12 antibodies also identified many in vivo target loci that are bound by these two proteins. 
Subsequent gel shift assays using the sequences obtained from these target loci revealed one 
potential DNA-binding motif for AEBP2, CTT(N)15-23cagGCC. Also, individual ChIP 
experiments further demonstrated that a subset of these identified loci are indeed occupied by 
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both the AEBP2 and SUZ12 proteins. These results are consistent with the initial prediction that 
AEBP2 may be a targeting protein for the mammalian PRC2 complex.  
Material and Method 
Global Protein Sequence Alignment 
AEBP2- and JING-related sequences were collected from NCBI, UniProt, EMBL and UCSC. 
ClustalW was used to create protein alignments, and the final outcome was produced and edited 
using CLC free workbench version 4.0.3 (CLC bio A/S, Denmark). The protein alignment was 
set using the following parameters: gap opening penalty = 10, gap extension penalty = 0.1.  
AEBP2 Isoform Confirmation through RT–PCR and Western Blot 
Total RNAs were isolated from several tissues of a 3-month-old male mouse using the Trizol 
RNA isolation kit (Invitrogen). These RNAs were reverse-transcribed using the RT-PCR kit 
(Invitrogen SuperScript system, Invitrogen). For the 5"-side splicing, the following primer sets 
were used: mAebp2-a1, 5"-CGGCCAGCGCTACACCCCAAGAACT-3"; mAebp2-a2, 5"-
GGGGAGCCGCTGAGCCGCATGGACT-3"; and mAebp2-b, 5"-
GAAGCATGCCTGGCACTGGTC-3". For the 3"-splicing, we used the following primer sets: 
mAb7-F, 5"-GATACTGCCTTGCTGTTGGACC-3"; mAbU2-R, 5"-
TCCATGCCATGTGGACTGCAG-3", and mAbU3-R, 5"-CTCCACTTCCACCTACAAGGA-3". 
The PCR with the mAb-a1 and mAb-b primer set were performed at an annealing temperature of 
61°C for 35 cycles. The remaining primer sets were amplified at an annealing temperature of 
60°C for 30 cycles. For the detection of the AEBP protein, we prepared crude tissue extracts 
from the brain and testis of 1-month-old mouse, and also a 14-day-old embryo using the T-PER 
Tissue Protein Extraction Reagent kit (Cat. 78510, Thermo Scientific). Each extract (10 #g) was 
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separated on 10% SDS–PAGE, transferred on to a PVDF membrane (Hybond-P, Amersham), 
and incubated with the anti-AEBP2 polyclonal antibody (Cat. 11232-2-AP, Proteintech Group).  
AEBP2 GST Fusion Protein Production 
Three different GST fusion proteins were produced through cloning different part of the mouse 
AEBP2 protein ( GenBank accession no. NM_178803). To construct these fusion constructs, we 
have amplified the coding region of AEBP2 using the following primer set: Acidic-mAb-F (5"-
ATGGCCGCCGCGCTCGCCGACATG-3") as a forward primer and mAebp2-b (5"-
ATTGCAAATGTCGTTCACTGTTTGCT-3") as a reverse primer for the fusion construct I, 
mAebp2-a (5"-ATGGACATAGACAGCACAATTTCCAG-3") as a forward primer and mAebp2-
b (5"-ATTGCAAATGTCGTTCACTGTTTGCT-3") as a reverse primer for the fusion construct 
II, and mAebp2-a (5"-ATGGACATAGACAGCACAATTTCCAG-3") as a forward primer and 
xbAebp2 (5"-CTGAAGTGTGTGGGTACATGGC-3") as a reverse primer for the fusion 
construct III. These products were first subcloned into the pCR4 TOPO vector (Invitrogen) for 
sequencing verification, and later subcloned into the BamHI and HindIII restriction enzyme sites 
of the pGEX-4T-1 vector (Amersham Biosciences). The clones were transformed into the BL21 
(DE3) competent cells (Strategen). The transformed cells were grown in LB media in 37°C to an 
absorbance value of 0.56 at 600 nm. The cells were further induced with 0.4 mM IPTG for 4 
hours. The cell pellets were first sonicated, and stored in –80°C for later use in gel shift assays.  
Electro Mobility Shift Assay (EMSA) 
EMSAs were performed as suggested by Promega with alterations in the DNA-binding buffer 
condition. For most of our EMSAs, we mainly used the NTEN buffer (100 mM NaCl, 1 mM 
EDTA, 20 mM Tris–Cl pH 6.0, 0.5% NP40). Each reaction contained 10 #g of GST fusion 
protein along with a given duplex probe (0.007 pmol per reaction), which were labeled with [$-32 
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P] ATP. The information regarding the sequences of all the duplex probes used for the current 
study is available upon request.  
ChIP Cloning and Individual ChIP Assays with Anti-AEBP2 and Anti-SUZ12 Antibodies 
We performed ChIP cloning experiments using two polyclonal antibodies: AEBP2 (Cat. 11232-
2-AP, Proteintech Group) and SUZ12 (Cat. ab12201, Abcam). The brain tissues of a 1-month-
old mouse were used as a starting material, and the detailed protocol for our ChIP cloning is 
available from our previous study (Huang et al., 2006). DNA products eluted by anti-AEBP2 and 
SUZ12 ChIP were individually subcloned into the pZErO-2 vector (Invitrogen, Carlsbad, CA). 
About 200–300 clones were selected and subsequently sequenced using the ABI3130XL 
automated DNA sequencer (Applied Biosystem).  
For individual ChIP experiment, the AEBP2 antibody (20 #l) was added into each fraction (500 
#l) of cross-linked and sonicated mouse brain tissue. One mouse brain (1 g) was usually divided 
into 10 fractions. We followed the protocol of ChIP assay provided by the Upstate company 
(Upstate Biotech.). The immunoprecipitated DNA was dissolved in 40 #l of TE, and 1 #l of this 
eluted DNA was used as template DNA for one PCR-based ChIP assay. PCR conditions are as 
follows: 95°C for 5 min, 40 repetitions of the following cycle of 90°C for 30 s, 60°C for 30 s, 
72°C for 30 s, and final extension at 70°C for 15 min. Each reaction included a pair of 25 ng of 
oligonucleotide primers.  The information regarding the sequence of each primer set is available 
in our website (http://jookimlab.lsu.edu/?q=node/36).  
Motif Analysis of ChIP-Cloned Sequences 
Both 5"- and 3"-end regions, 4 bp in length, corresponding to the recognition sites for restriction 
enzymes were removed from each ChIP sequence for motif analyses. Any regions containing 
repeat elements were also removed from each ChIP sequence using RepeatMasker 
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(http://www.repeatmasker.org/cgi-bin/WEBRepeatMasker). Our motif analyses used a total of 
126 and 71 sequences that were obtained from AEBP2 and SUZ12 ChIP-cloned sequences, 
respectively. A standalone MEME (4.0.0) (http://meme.sdsc.edu/meme/cgi-bin/meme.cgi) was 
used to derive overrepresented motifs among each set of the ChIP-cloned sequences. We set 
parameters to ensure that at least a half of the sequences contain potential motifs in each set of 
ChIP sequences using a ‘-minsites’ parameter. We used the following parameters: -minsites (a 
half number of the sequences), -minw 5, -nmotifs 3, -revcomp, -dna. MAST (4.0.0) 
(http://meme.sdsc.edu/meme/cgi-bin/mast.cgi) was also used for the motif occurrence test with 
default setting.  
Results 
Identification of AEBP2-Related Sequences from Vertebrates and Flying Insects 
The protein sequence of mouse AEBP2 (GenBank accession no. NP_001005605, 496 amino 
acids long) was used to identify its related sequences from all available genome sequences. This 
search identified six AEBP2-related sequences from flying insects, including flies, mosquitoes, 
honeybees, beetles, and wasp. These insect sequences were previously identified as JING. The 
same search also identified 22 related sequences from vertebrates, ranging from urochordates to 
placental mammals: one sea urchin, five fish, one lizard, one chicken, 14 mammal sequences. 
The average sizes of the predicted ORFs (Open Reading Frames) for these AEBP2-related 
sequences are as follow: 1744 amino acids for insects’ JING, 450 amino acids for fish's AEBP2, 
and 500 amino acids for mammalian AEBP2. The sizes of the AEBP2 sequences identified from 
lizard, frogs, sea urchins, cannot be determined due to the incompleteness of their genome 
sequences. All these AEBP2-related sequences are available at 
http://jookimlab.lsu.edu/?q=node/36.  
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The amino-acid sequences of 20 full-length AEBP2-related sequences were used for global 
sequence alignment (Figure 2.1).  
 
 
Figure 2.1. Global protein sequence alignment of AEBP2 and JING. AEBP2 and JING 
protein sequences of different organisms were aligned using the ClustalW program. Different 
amino acids are represented in different colors and shades. The conservation level of each 
position is indicated in the graph below the alignment. Six conserved domains are indicated with 
different colors and patterns. The mouse AEBP2 protein was used as a reference to indicate the 
position of each conserved domain. The zinc finger and basic domains are the most conserved 
and show sequence conservation from flying insects to mammals. The zoom-in version of this 
alignment is available as Supplementary Data 5 or the following website (http://jookimlab. 
lsu.edu/?q=node/81). 
 
As shown in Figure 2.1, the mammalian AEBP2 sequences can be divided into six protein 
domains: acidic, neutral, serine-rich, zinc finger, basic and lysine-rich domains. Among these six 
domains, two domains (zinc finger and basic) show the highest levels of amino-acid sequence 
conservation among all different lineages.  The two domains of the mammalian AEBP2 (a.a. 
256–496 in mouse AEBP2 Figure 2.2A) show an average of 38% amino acid sequence identity 
with those of the insect JING (Figure 2.2A).  The serine-rich domain (a.a. 202–255) also shows 
high levels of sequence conservation: 83% amino acid sequence identity between the mammal 
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and fish lineage.  In contrast, the two domains located in the N-terminal portion of AEBP2 are 
lineage-specific.  Although these two domains show an average 90% amino acid sequence 
identity between the mammalian species, these domains do not show any obvious similarity to 
the respective regions of the AEBP2 sequences derived from insects and fish.  The acidic domain 
of mammalian AEBP2 is mainly characterized by arrays of glutamic and aspartic acid residues, 
whereas the neutral domain is characterized by arrays of glycines and serines. The AEBP2 
sequences of the fish lineage also have similar acidic and neutral domains, displaying 38% 
amino acid sequence identity within the fish lineage. These two domains are localized within one 
large exon in both mammals and fish (Figure 2.2B), and the sequences of this exon in both 
lineages exhibit tandem repeat structure with high CpG densities. As such, many 
insertions/deletions are detected between the two closely related species of both mammals and 
fish (data not shown).  On the other hand, the lysine-rich domain located in the C-terminus of 
mouse AEBP2 is found only in mammals, but is well conserved within mammalian species (a.a. 
497–511). 
Overall, mammalian AEBP2 is comprised of six protein domains: four domains are 
lineage-specific whereas two domains (zinc finger and basic) appear to be well conserved 
throughout all the lineages. 
Exon Structure and Isoforms of Mammalian AEBP2 
Inspection of all the available cDNA and EST (Expressed Sequence Tag) sequences derived 
from the mouse Aebp2 gene revealed that mouse Aebp2 is comprised of 11 individual exons that 
spread over a 60-kb genomic interval in mouse chromosome 6 (Figure 2.2B). A single exon 




Figure 2.2. Exon structure and alternative splicing of the mouse Aebp2 gene. (A) The same 
colors and patterns as Figure 1 were used to represent different protein domains. The percent 
identities were calculated through comparing the amino-acid sequences of AEBP2 from 
individual organisms vs. the mouse. The N terminus of the insects’ JING (dotted-lines) was 
omitted in this comparison due to the lack of any detectible sequence similarity. The AEBP2 of 
the fish lineage also has similar acidic and neutral domains, but these do not show any similarity 
to those of mammalian AEBP2 (indicated with a green box). (B) Isoforms and stage-specific 
expression of the mouse Aebp2. A total of 11 exons have been found in the mouse Aebp2 so far. 
Three START codons are indicated: two within Exon 1b and the third one in Exon 2. Three 
STOP codons are also indicated within exons 8, 9a and 9b. Alternative splicing of these exons 
could result in at least six different isofoms, including the two major forms detected in this study, 
Isoform 1 (52 kDa) and Isoform 2 (31 kDa). (C) Alternative splicing confirmed through RT–
PCR. This analysis used total RNA from individual tissues, the different amounts of which were 
normalized to an internal control gene, p53. The combination of exons 1a and 2 is highly 
expressed in a 14-day-old embryo, which belongs to Isoform 2. (D) Western blot of the mouse 
AEBP2. Isoform 1 (52 kDa) is dominant in the most tissues examined, while Isoform 2 (31 kDa) 















The following three exons (exons 2–4) encode the serine-rich domain and the three zinc finger 
units (a.a. 201–345), and the next four exons (exons 5–8) encode the basic domain (a.a. 346–
496). This exon structure also involves two sets of alternative splicing: one is between the two 
5"-end exons (1a and 1b) and the other is between three individual 3"-end exons (8, 9a and 9b). 
The first alternative splicing yields the two different forms of AEBP2 cDNAs: Isoform 1 with 
exon 1b and Isoform 2 with exon 1a (Figure 2.2B). The Isoform 1 cDNA has three potential 
START codons that are in-frame with the rest of the AEBP2 exons. The first two are located 
within exon 1b, and the third one is within exon 2. In contrast, exon 1a does not contain any in-
frame ATG codon, and thus the Isoform 2 cDNA starting from exon 1a likely uses the third 
START codon located within exon 2. Since the two potential START codons for Isoform 1 and 2 
are separated by 222 amino-acid residues, a large protein size difference is predicted between 
these two forms. Also, the acidic and neutral domains should be included only in the larger form 
(Isoform 1), but not in the smaller form (Isoform 2).  The second alternative splicing occurs 
between several 3"-end exons: Exon 8, 9a and 9b. The first form of the 3"-end alternative splicing 
simply ends at Exon 8 with its STOP codon and 3"-UTR (Figure 2.2B). The second form splices 
out the 3"-UTR of Exon 8, and join only the coding region of Exon 8 (named Exon 8s) to another 
downstream exon (exon 9a). Exon 9a has an additional 14-amino-acid-long coding region with 
its STOP codon. In fact, this small peptide region from exon 9a corresponds to the lysine-rich 
domain that is conserved within every mammalian species (Figures 2.1 and 2.2A). The third 
form of the 3"-end alternative splicing connects exon 8s to another further downstream exon 
(exon 9b), and this form also has an additional 7-amino-acid-long coding region. The 
evolutionary conservation of this exon is, however, currently unknown. According to our own 
survey on ESTs and cDNAs, most cDNAs derived from different tissues start with exon 1b and 
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end with exon 8 (496 a.a. long), but a subset of cDNAs from early embryonic stages start with 
exon 1a, and end with either exons 8 or 9a (274 or 288 a.a. long). The other combinations of 
cDNAs are also likely, but the above two forms are believed to be the major forms for mouse 
AEBP2 cDNAs.  The two sets of alternative splicing predicted from cDNA sequences were 
tested through RT–PCR-based experiments using total RNAs isolated from several mouse tissues 
and cell lines (Figure 2.2C). As shown in Figure 2.2C (second and third row), the exon 
combination of 1b and 2 (1b + 2) was detected throughout all the tissues tested. The exon 
combination of 1a and 2 (1a + 2) was similarly detected in all the samples except the Neuro2A 
cell line. The overall expression levels of the 1b + 2 combination were higher than those of the 
1a + 2 combination. However, this trend was reversed in the embryonic tissues: the expression of 
the 1a + 2 combination was much higher than that of the 1b + 2 combination. This is also 
consistent with the fact that all of the available EST clones containing the 1a+2 combination 
were derived from early embryonic tissues. The detection of these two alternative first exons 
further suggests the presence of two alternative promoters for mouse Aebp2: one may be 
responsible for the ubiquitous expression whereas the other one for the embryo-specific 
expression. We also performed another set of RT–PCR analyses to confirm the presence of the 
3"-end alternative splicing (Figure 2.2C, fourth and fifth row). Since exon 9a is still part of the 
3"-UTR of exon 8, we avoided testing the second exon combination (7 + 8s + 9a). We mainly 
analyzed two different combinations of the 3"-end alternative splicing (7 + 8 and 7 + 8s + 9b). 
Both exon combinations were detected in most of the tissues examined, but the expression levels 
of the 7 + 8 combination appear to be higher than those of the 7 + 8s + 9b combination. Overall, 
RT–PCR analyses indeed confirmed the presence of two alternative splicing patterns, and 
detected somewhat stage and tissue specificity of these splicing patterns.  
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We further tested the presence of multiple isoforms of the AEBP2 protein with western blot 
experiments using a polyclonal antibody raised against the human AEBP2 protein (Figure 2.2D). 
This analysis detected two main forms of AEBP2 (52 and 31 kDa, respectively). The larger form 
(52 kDa) was detected in the HeLa nuclear extracts as well as in the several tissues of the mouse, 
including brain and testis. Detection of another band in the brain sample was likely caused by 
non-specific binding to other unknown proteins. The 52-kDa protein appears to correspond to the 
largest ORF predicted from Isoform 1 cDNAs based on its similar size and ubiquitous expression 
in most tissues. In the brain of a 14-day-old embryo, however, the same analysis detected only 
the smaller form (31 kDa). The 31-kDa protein likely corresponds to the ORF derived from 
Isoform 2 cDNAs based on its smaller size and limited expression in embryonic stages. Due to 
the limited separation capability of SDS-PAGE gel electrophoresis, however, it is currently 
unknown whether these two isoforms also have different C-terminal endings, as predicted from 
the 3"-end alternative splicing. Nevertheless, the above analysis confirmed the existence of two 
major forms of AEBP2 in vivo: the adult-specific larger form (52 kDa) and the embryo-specific 
smaller form (31 kDa).  
DNA-Binding Motifs of AEBP2 
To characterize DNA-binding motifs for AEBP2, we made three GST-fusion constructs 
containing different isoforms of mouse AEBP2: Construct I (a.a. 1–496) corresponding to the 
52-kDa larger form, Construct II (a.a. 223–496), corresponding to the 31-kDa smaller form, and 
Construct III (a.a. 223–348), corresponding to a truncated version lacking the basic domain. All 
of these GST-fusion proteins were successfully expressed in bacteria. However, only the two 
GST-fusion proteins from Constructs II and III exhibited some levels of DNA-binding activity. 
The reason for the inactivity of the GST-fusion protein I is currently unknown. We also tested 
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the binding capability of the GST-fusion protein II to the sequences of several individual DNA 
fragments, which have been derived from ChIP cloning experiments designed to identify the in 
vivo target loci of the AEBP2. This will be described in detail in the following section. Among 
these short sequences, one sequence named T1 showed consistently high levels of DNA-binding 
affinity to the GST-fusion protein II. Thus, we have selected and used this particular sequence as 
a main probe for our DNA-binding motif assays (Figure 2.3). Several mutant series of the T1 
duplex probes were designed and used for our DNA binding motif studies of AEBP2. First, an 
internal 28-bp-long region of the T1 sequence (8th to 35th position) was divided into four 
individual 7-bp-long sections, and the sequence of each section was changed into a 7-bp-long 
stretch of A's (Probe II-1 through 4). Each of these mutant probes was used as a competitor to the 
P32-labeled T1 probe for gel shift assays (Figure 2.3A). A shift band was completely abolished 
in a self-competition experiment, using a 100 to 1 molar ratio of the P32-unlabeled to labeled 
probes (Figure 2.3A, Lane 1). Similarly, the third mutant (lanes 6 and 7) competed and 
abolished the band, indicating that this region is dispensable for the binding activity.  
In contrast, the three remaining mutants did not compete at all (lanes 2, 3, 4, 5, 8, 9), indicating 
that the three regions covered by these mutants are important for the binding to AEBP2.  This 
initial series of competition experiments demonstrated that the two regions (8th to 21st and 29th 
to 35th position) of the T1 sequence are critical for the binding to AEBP2.  These two regions 
were further analyzed using a second series of mutants, each of which has a 3-bp-long stretch of 
A's (Figure 2.3B). This series of experiments identified 3 smaller regions showing relatively 
weak competition (Figure 2.3B, lanes 6, 8, 9, marked with asterisk), indicating that these three 




Figure 2.3. DNA-binding motifs of AEBP2. Gel shift assays of the GST-AEBP II fusion 
proteins. (A) Competition assay with the first series of mutants (II-1, II-2, II-3, II-4). Each 
contains an internal 7-bp-long region substituted with a stretch of As. (B) Competition assay 
with the second series of mutants. Each contains a 3-bp-region substituted with a stretch of As. 
Mutants 6, 8 and 9 did not compete well (as indicated with asterisk), and thus these three small 
regions are thought to be the most critical for the AEBP2 binding. (C) The T1 probe was also 
competed with other short sequences derived from the ChIP cloning experiment using the 
AEBP2 antibody. The actual sequences for these ChIP fragments are shown on the right column. 
(D) Competition assay with different probes: the AE-1 probe from the original sequence that was 
used to identify the AEBP2 (1), the AB-13 probe from an independent ChIP-derived sequence 
with high affinity to AEBP2, the Zipped probe with the II-3 region removed and the Wide probe 






We also performed another independent series of gel shift assays using the DNA sequences 
derived from the 20 shortest DNA fragments derived from the ChIP cloning experiments using 
the AEBP2 and SUZ12 antibodies (Figure 2.4).  This survey identified four individual 
sequences showing high levels of binding affinity to AEBP2 (Figure 2.3C, S8, S10, AB-13 and 
S17).  Further inspection of the four sequences, averaging 50 bp in length, revealed that all of 
these sequences share two small motifs with the T1 sequences, CTT and GCC.  However, the 
distance between these two motifs is somewhat variable among these potential binding sites of 
AEBP2, ranging from 15 to 23 bp in length. Thus, the effect of spacing between motifs was 
tested using two mutants of the T1 sequences (Figure 2.3D, lanes 6–9).  The spacing region of 
the T1 sequence was either deleted (Zipped) or duplicated (Wide). The Zipped probe did not 
compete but the Wide probe competed very well, demonstrating that the spacing between the 
two motifs requires some minimum distances, but that the size can be variable without any major 
effect on the binding affinity to AEBP2.  We also tested the binding affinity of the original 
sequence that was used to identify the AEBP2 protein ((He et al., 1999); AE-1, lanes 2 and 3). 
This sequence competed at some levels, but the binding affinity was much lower than the other 
sequences used for this study.  We repeated the above experiments using GST-fusion protein III, 
which lacks the basic domain.  The results did not show any difference from those of GST-fusion 
protein II (data not shown).  This suggests that the three Gli-type zinc finger motifs shared by 
both fusion proteins are mainly responsible for the DNA-binding activity of AEBP2.  In sum, the 
above series of experiments identified a DNA-binding motif for AEBP2, which displays an 
unusual bipartite motif structure, CTT(N)15-23cagGCC with the lowercase bases being less 
critical for binding.  
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ChIP Cloning of in vivo Target Loci Bound by AEBP2 and SUZ12 Proteins  
A series of ChIP cloning experiments were performed to identify in vivo target loci bound by 
AEBP2 (Figure 2.4).  We previously developed a modified version of ChIP cloning method, 
which can be used to directly clone very short DNA fragments without PCR amplification 
(Huang et al., 2006).  This method performs restriction enzyme digestion with 4-bp cutters, such 
as Sau3AI or Tsp509, directly on the DNA while it is still cross-linked to a target protein as a 
chromatin complex.  This enzyme digestion usually generates much shorter DNA fragments that 
are compatible with subcloning.  Using two polyclonal antibodies against AEBP2 and SUZ12, 
we have generated two individual libraries containing ChIP-derived DNA fragments.  We have 
sequenced a subset of these two libraries, 250 and 165 clones for AEBP2 and SUZ12, 
respectively.  The average length of the inserts from each library was about 140 bp in length. 
Individual sequences are available in our website (http://jookimlab.lsu.edu/?q=node/36) and also 
the associated information can be viewed using a custom track view of the UCSC genome web 
browser (http://genome.ucsc.edu/cgi-
bin/hgTracks?db=mm9&hgt.customText=http://jookimlab.lsu.edu/sites/default/files/Aebp2_bed.
txt).  This method performs restriction enzyme digestion with 4-bp cutters, such as Sau3AI or 
Tsp509, directly on the DNA while it is still cross-linked to a target protein as a chromatin 
complex.  This enzyme digestion usually generates much shorter DNA fragments that are 
compatible with subcloning.  Using two polyclonal antibodies against AEBP2 and SUZ12, we 
have generated two individual libraries containing ChIP-derived DNA fragments.  We have 





Figure 2.4. ChIP cloning scheme and experimental strategies. Our modified ChIP cloning 
method has one additional step compared to other existing protocols: the restriction enzyme 
digestion step (step 4) right before the elution step. This allows immediate cloning of shorter 
ChIP DNA fragments without PCR amplification. Also, this shortening of ChIP fragments 
further trims other unnecessary long regions from either side of each ChIP fragment while 
preserving the actual binding site for a given DNA-binding protein. This further facilitates 
accurate prediction of DNA-binding motifs. The isolated ChIP fragments were subsequently 
used for the following three experiments. First, we used the sequences derived from the shortest 
ChIP fragments as probes for our gel shift assays of AEBP2. Second, we used the sequences 
from the ChIP cloning to identify enriched DNA motifs. Third, we also identified in vivo target 
loci for both AEBP2 and SUZ12. These confirmed loci were later tested for the co-occupancy by 
AEBP2 and SUZ12. 
 
The average length of the inserts from each library was about 140 bp in length. Individual 
sequences are available in our website (http://jookimlab.lsu.edu/?q=node/36) and also the 




txt).  Initial inspection of the sequences from these two libraries derived the following 
conclusions.  First, both libraries contain fractions of repeat sequences, 124/250 for the AEBP2 
set and 94/165 for the SUZ12 set.  Second, the remaining non-repeat sequences of both sets 
mapped closely to gene regions of the mouse genome.  The list of the genes associated with each 
set was compared with the list of the mouse genes that are known to be bound by the PRC2 
(Boyer et al., 2006).  This comparison confirmed that 53 out of the 126 sequences of the AEBP2 
set (42%) were derived from the known PcG target loci while 18 of the 71 sequences of the 
SUZ12 set (25%) came from the PcG target loci.  It has been shown that only a small fraction of 
mammalian genes are controlled by the PRC2 (less than 5% of the entire gene set of mammals) 
(Boyer et al., 2006).  Thus, the observed high levels of enrichments of the PcG downstream 
genes among the ChIP cloning sets of AEBP2 (42%) and SUZ12 (25%) strongly suggest that 
both proteins, AEBP2 and SUZ12, are likely involved in the targeting of the PRC2 complex. 
Some of the notable PcG loci that were identified through our ChIP cloning trials include: Grm8, 
Abcc3, and Phkb from the AEBP2 set and Pax1, Acvrinp1 and A20Rik from the SUZ12 set. The 
summary of this comparison is available on our website (http://jookimlab.lsu.edu/?q=node/36).  
Third, analysis of the non-repeat sequences by the MEME program 
(http://meme.sdsc.edu/meme/intro.html) revealed the presence of several DNA motifs that were 
overrepresented within each set of ChIP sequences.  The two most significant motifs from each 
set are shown in sequence logo format (Figure 2.5).  The first motif of the AEBP2 set is 22 bp 
long, and shared by 77 out of the 126 individual sequences.  Interestingly, this motif contains 
several small regions showing sequence similarity to the two 3-bp-long critical regions, which 
were shown to be critical for the binding to AEBP2 by our previous gel shift assays, CTT and 




Figure 2.5. Enriched motifs within the AEBP2 and SUZ12 ChIP sequences. Motifs were 
predicted with each set of AEBP2 and SUZ12-ChIP sequences using the MEME program 
(http://meme.sdsc.edu/meme4/cgi-bin/meme.cgi). (A) The two most significant motifs identified 
from each set are shown in the sequence logo format. (B) The most significant motif from the 
AEBP2 set was shown with the two small motifs, which have been also independently identified 
through gel shift assays. This most significant motif was also aligned with 20 individual 
sequences. 
 
We performed another gel shift assays using several AEBP2-ChIP fragments, which are shown 
in Figure 2.5B, and the results confirmed again that these ChIP fragments indeed contain the 
DNA-binding sites for AEBP2 (http://jookimlab.lsu.edu/?q=node/36). The second motif from the 
AEBP2 set is also 22 bp long, and displays a somewhat similar C-rich consensus sequence as the 
first motif. This motif is shared by the 56 individual sequences of the AEBP2 set. Similar 
analyses also identified two motifs from the SUZ12 set, which are shared by 45 and 35 
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sequences of the total 71 individual sequences, respectively.  It is interesting to note that both 
motifs contain small regions similar to the GAGA motif, which is a frequent DNA motif in the 
Polycomb Response Element (PRE) of Drosophila (Ringoes and Paro, 2004, Ringoes et al., 
2003).  However, the two motifs from the SUZ12 set are shorter and also shared by fewer of the 
individual sequences than the two motifs from the AEBP2 set.  This suggests that the sequences 
of the SUZ12 set are more heterogeneous than those of the AEBP2 set.  In sum, many in vivo 
target loci of AEBP2 appear to be derived from the known PcG target regions, and these loci 
display C-rich sequences with several small motifs, which are reminiscent of the two critical 
DNA-binding sites of AEBP2.  
Co-occupancy Test with AEBP2 and SUZ12 ChIP Assays 
The identified genomic loci by AEBP2 and SUZ12-ChIP cloning were further analyzed using 
individual ChIP experiments (Figure 2.6).  These individual ChIP experiments were performed 
to measure what fraction of each library contains genuine in vivo target loci for each protein. 
According to the results from four different trials, 18 out of 19 tested loci from the AEBP2 set 
showed consistent enrichment with the AEBP2 antibody, indicating that about 94% of the 
AEBP2 set likely contains genuine in vivo target loci.  A similar test indicated that about 70% of 
the SUZ12 set (16/23) likely contains in vivo target loci.  The representative results from these 
series of ChIP experiments are shown in Figure 2.6A and the remaining portion of the results 
along with other relevant information are also available on our website 
(http://jookimlab.lsu.edu/?q=node/36).  
Since AEBP2 is a potential targeting protein for PRC2, we further tested this possibility 
through performing co-occupancy tests.  If the two proteins, AEBP2 and SUZ12, bind to target 
loci together as a protein complex, many confirmed target loci from one protein (AEBP2) should 
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be also positive with another ChIP experiment using the antibody against the second protein 
(SUZ12), and vice versa.  The results from this co-occupancy test are as follows.  Out of the 19 
AEBP2 loci tested, 15 (79%) were positive with the SUZ12-ChIP experiments.  None of the 
negative loci from the AEBP2-ChIP were positive with the SUZ12-ChIP.  On the other hand, 16 
out of the 23 confirmed loci of the SUZ12 set (70%) were also positive with the AEBP2-ChIP. 
We also extended this co-occupancy test to the known target loci of the PcG complex. Out of the 
six loci tested, three loci turned out to be positive with both AEBP2 and SUZ12-ChIP 
experiments (Figure 2.6A and B; http://jookimlab.lsu.edu/?q=node/36).  We also included YY1 
ChIP experiments to test if these loci are bound by YY1.  None of the tested loci were positive 
with the YY1-ChIP, suggesting that YY1 may not be involved in the targeting of the mammalian 
PRC2 to these loci.  The HoxA9 locus was analyzed in further detail by including two additional 
primer sets.  The precise PcG target region within this locus is located 3.75-kb upstream of the 
gene as demonstrated in the high levels of the DNA enrichment by the SUZ12-ChIP experiments 
(Figure 2.6B).  The two other regions also show some levels of the enrichment with the SUZ12-
ChIP, which is consistent with the previous study (Cao et al., 2004). However, the AEBP2-ChIP 
showed high levels of the enrichment only at the 3.75-kb upstream region, demonstrating high 
levels of target selectivity by the AEBP2-ChIP experiment. In sum, the co-occupancy tests 
revealed that an unusually large fraction of in vivo target loci are co-occupied by both AEBP2 






Figure 2.6. Co-occupancy test of the gene loci identified through AEBP2 and SUZ12 ChIPs. 
(A) Co-occupancy test of the genes identified from AEBP2 and SUZ12-ChIP sequencing. The 
left panel indicates the genes derived from each round of ChIP sequencing. Grm8, Abcc3 and 
Phkb were derived from the AEBP2-ChIP sequencing, while Pax1, Acvrinp1 and A20Rik were 
from the SUZ12-ChIP sequencing. The three loci (Grm8, Abcc3 and Phkb) were first tested 
through individual ChIP assays using the AEBP2 antibody, and later using another antibody 
(SUZ12) for the co-occupancy test. This was also repeated for the SUZ12 set (Middle). A subset 
of the known Polycomb target loci (Barx1 and Zic1) were also included for the co-occupancy 
test (bottom). (B) Co-occupancy of AEBP2 and SUZ12 on the HoxA9 locus. The co-occupancy 
of AEBP2 and SUZ12 was only detected at the 3.75-kb upstream region of the transcription start 
site of HoxA9. We also performed another independent ChIP using the YY1 antibody to test if 




In the current study, we have characterized AEBP2 in terms of evolutionary conservation, 
genomic structure, DNA binding motifs and potential targeting roles for the Polycomb group 
repression complex 2 (PRC2).  AEBP2 contains two evolutionarily conserved protein domains, 
the zinc finger and basic domains, and these two domains are also shared by the flying insect 
protein JING.  jing has recently been recognized as a member of the PcG in Drosophila. 
Mammalian AEBP2 is driven by two alternative promoters and produces at least two major 
forms of the protein, and these isoforms show developmental stage-specific expression patterns: 
the adult-specific larger form (52 kDa) and the embryo-specific smaller form (31 kDa).  The 
AEBP2 protein binds to a DNA-binding motif with an unusual bipartite structure, CTT(N)15-
23cagGCC.  A large fraction of AEBP2's target loci also map closely to the known target loci of 
the mammalian PRC2.  We further confirmed that many of these loci are indeed co-occupied by 
the two proteins AEBP2 and SUZ12.  This supports the prediction that AEBP2 is a targeting 
protein for the mammalian PRC2 complex.  
Global alignment of 20 AEBP2 sequences identified two evolutionarily conserved 
domains, the zinc finger and basic domains, which are located at the C-terminus of the protein 
(Figure 2.1).  These two domains maintain very high levels of sequence conservation throughout 
all the vertebrates, greater than 80% sequence identity in the 280 amino-acid long region.  
Similar domains are also found even in the flying insect protein JING, sharing an overall 38% 
sequence identity with AEBP2 (Figure 2.2A).  Although the observed sequence similarity is 
relatively low, the insects’ jing is thought to be a homolog to vertebrates’ AEBP2 based on the 
following reasons.  First, although the zinc finger domains of both genes are comprised of three 
typical Gli-type finger units that are quite prevalent in eukaryotic genome, the 2nd finger shows 
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relatively high levels of sequence similarity (63%) between the two groups.  Interestingly, the 
second finger is also three amino acids longer than typical Gli-type finger units (He et al., 1999).  
Yet, this unique variation is also detected in all the sequences of both AEBP2 and JING proteins 
(http://jookimlab.lsu.edu/?q=node/36).  Second, the basic domain is characterized by a stretch of 
basic (Lys and Arg) amino-acid residues at the beginning and another stretch of hydrophobic 
(Leu, Val and Ile) and aromatic (Phe, Tyr and Trp) amino acid residues at the end.  According to 
database search, this unusual domain is only found in the two proteins, AEBP2 and JING.  
Furthermore, the unique combination of this novel basic domain along with three Gli-type zinc 
finger units is found again only within these two proteins.  Therefore, it is highly likely that 
vertebrates’ AEBP2 and the flying insects’ JING have been derived from a common ancestor.  
According to recent genetic studies in flies, the jing locus genetically interacts with several 
members of PcG members (Culi et al., 2006).  This further suggests that AEBP2 and JING still 
play a similar role, perhaps in the PcG-mediated repression.  If this is the case, the two conserved 
domains likely play the most central roles for this repression mechanism, DNA binding by the 
zinc finger units and protein–protein interaction by the basic domain.  
One of the unexpected features associated with the Aebp2 gene is the presence of several 
combinations of alternative splicing, which involve the 5"-end two exons and 3"-end three exons 
(Figure 2.2B–D).  In principle, six different types of AEBP2 protein isoforms are possible 
although we have detected only two major forms through western blot analyses.  The expression 
of these two major forms is very developmental stage-specific: the larger form (52 kDa) is 
mainly detected in adult tissues, whereas the smaller form (31 kDa) is found only in embryonic 
tissues.  This stage-specific expression is thought to be driven by the two different promoters 
located upstream of the two alternative first exons.  According to our own surveys using the EST 
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database, a similar 5"-end alternative splicing of AEBP2 is also detected in other mammals, and 
the expression of each of the two splicing variants can be easily categorized into either 
embryonic or adult-specific.  In the other vertebrates and invertebrates, however, there appears to 
be only one first exon for AEBP2 and JING, and also the expression pattern of this cDNA form 
appears to be spatially and temporally ubiquitous.  This suggests that the alternative splicing of 
AEBP2 and stage-specific expression are unique features found only in mammals.  Then, what is 
the major impetus for the sudden implementation of this alternative splicing for the mammalian 
AEBP2?  This could be explained by the actual products of the alternative splicing: a smaller 
embryonic form with two conserved domains versus a larger adult form with additional lineage-
specific domains (Figure 2.2). Given the similarities in domain structure between the smaller 
form and other vertebrate AEBP2 proteins, the smaller form is likely involved in more 
fundamental biological processes than the larger form, such as determining the pattern and axis 
of animal body during early development.  On the other hand, the larger form with lineage-
specific protein domains is likely involved in cellular processes that are more species-specific, 
such as determining the lineage and location of different cell types within the adult tissues.  It is 
interesting to note that the smaller form with conserved domains participates in earlier 
developmental processes than the larger form with additional lineage-specific domains.  This 
could be another case of ontogeny recapitulating phylogeny in animal evolution (Gould, 1977).  
Overall, the alternative splicing and subsequent formation of mammalian AEBP2 isoforms 
represents a case where alternative splicing has driven functional division and adaptation of 
genes.  
According to DNA-binding motif studies (Figure 2.3), AEBP2 binds to a consensus 
sequence with bipartite structure, CTT(N)15-23cagGCC, and this binding is mainly driven by the 
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three zinc finger units.  This consensus DNA-binding motif has been further substantiated by the 
independent observation that the in vivo target loci of AEBP2 also show similar motifs (Figure 
2.5).  However, the AEBP2 binding to a bipartite structure motif was unexpected given the fact 
that the three zinc finger units are juxtaposed right next to each other.  This suggests that the 
recognition of the two smaller motifs within the bipartite motif, which is separated by a spacing, 
(N)15-23, may be driven by individual zinc finger units of either one or two proteins.  The model 
of single protein binding posits bending of the DNA because of the predicted close proximity 
between individual fingers, whereas the model involving binding by two proteins hypothesizes 
potential dimer formation of the AEBP2 protein.  We favor the first model based on the 
following reasons.  First, the truncated version of AEBP2, GST-fusion protein III, lacks any 
domains that could function in dimerization, and it still showed unchanged binding preference to 
the bipartite motif (data not shown).  Second, the bipartite motif tends to show higher affinity to 
AEBP2 when the spacing region, (N)15-23, of the bipartite motif is either homopolymeric or 
polypyrimidine stretch sequences, such as polyA or poly(CT).  These types of sequences are 
known to be common in bending regions of the genome (De’ jardin, 2004).  This is further 
supported by our independent observation that many confirmed target loci of AEBP2 also exhibit 
polypyrimidine sequence structures (Figure 2.5).  Although we cannot rule out the other 
possibilities of DNA binding driven by the dimer structure of AEBP2, the above results suggest 
potential binding of AEBP2 to bent DNA.   
The co-occupancy test with the ChIP experiment clearly demonstrated that AEBP2 and 
SUZ12 bind to similar genomic regions (Figure 2.6).  Since none of the PRC2 core proteins are 
known to be DNA-binding proteins, this further implicates that AEBP2 may act as a targeting 
protein for this complex.  According to our recent data from a mouse model disrupting the Aebp2 
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locus (H. Kim et al., unpublished results), some of the known PcG downstream genes are indeed 
de-repressed in these mutant mice (http://jookimlab.lsu.edu/?q=node/36), further confirming this 
possibility.  Also, the previously reported activity of AEBP2 as a transcriptional repressor 
supports this possibility (He et al., 1999).  We do not predict, however, all of the identified target 
loci of AEBP2 to be PcG target loci based on the following reasons.  First, we expect that 
AEBP2 should be also involved in many other cellular processes besides the predicted PcG-
targeting role based on its evolutionary age and also various protein isoforms detected in 
mammals.  YY1 is an example of a similar case: its role has diversified tremendously from its 
original evolutionarily conserved role in the Polycomb-mediated repression since the split of 
insects and vertebrates (Gordon et al, 2006; Kim, 2007).  Second, as demonstrated in flies, PcG 
targeting is likely mediated through a combination of several DNA-binding proteins along with 
critical DNA structures which are yet unrevealed (Ringose et al., 2003).  A similar conclusion 
has been drawn from the current study: although many SUZ12 confirmed loci are also bound by 
AEBP2, the DNA-binding motifs of AEBP2 were not significantly overrepresented in this pool 
of the genomic sequences (Figure 2.5).  This suggests that AEBP2 may be one of several DNA-
binding proteins involved in the targeting of the mammalian PRC2.  In that regard, 
characterizing the functional contexts of each of the AEBP2 binding to the identified in vivo 
target loci will be of great interest in the near future.  
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AEBP2 AS AN EPIGENETIC REGULATOR OF  




























Aebp2 is an evolutionarily well conserved Gli-type zinc finger gene that is found in species 
ranging from flying insects to humans (Kim et al. 2009).  This gene was initially identified due 
to its binding capability to the promoter of the adipocyte P2 gene, hence named Adipocyte 
Enhancer Binding Protein 2 (Aebp2) (He et al. 1999).  Since then, Aebp2 has been increasingly 
recognized as a component of the mammalian Polycomb Repression Complex 2 (PRC2) due to 
its frequent co-purification with the other components of PRC2 (Cao and Zhang 2004; Peng et al. 
2009; Shen et al. 2009; Li et al. 2010; Pasini et al. 2010).  According to recent studies, AEBP2 is 
indeed a DNA-binding protein with its consensus DNA-binding motif being CTT(N)15-
23cagGCC.  Also, the majority of its genome-wide target sites overlap very well with the known 
target loci of PRC2, suggesting AEBP2 is a targeting protein for the mammalian PRC2 (Kim et 
al. 2009).  The in vivo functions of Aebp2 are currently unknown, but are likely involved in cell 
migration based on the following observations.  First, jing, a Drosophila homolog of Aebp2, was 
identified as a gene controlling the border cell migration within eggs (Liu and Montell 2001).  
Second, the expression of mouse Aebp2 is mainly detected within cells of neural crest origin (this 
study), which are notable for their migratory capability during vertebrate development.  Thus, the 
in vivo roles of Aebp2 are most likely associated with the migration and development of neural 
crest cells.    
The neural crest cell (NCC) is a transient, multipotent cell population that gives rise to 
many different cell types for vertebrate organs, including those in the enteric nervous system and 
endocrine system, facial cartilage and bone, and melanocytes.  One unique feature associated 
with NCC is its migration capability from the neural crest to various locations in the developing 
vertebrate (Sauka-Spengler and Bronner-Fraser 2008a, 2008b).  Several signaling pathways are 
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involved in this migration process, including RET and EDNRB pathways.  RET encodes a 
receptor tyrosine kinase that recognizes GDNF (Glial cell line-Derived Neurotrophic Factor) 
whereas EDNRB (Endothelin Receptor B) encodes a G protein-coupled receptor that recognizes 
EDN3 (Endothelin 3).  Mutations in these two pathways quite often manifest as human genetic 
disorders, including Hirschsprung’s disease (HSCR) and Waardenburg syndrome (WS).  The 
disease phenotype of HSCR is obstruction of the gastrointestinal tract, resulting in a 
pathologically enlarged colon, or ‘megacolon.’  This is caused by the absence of NCC-derived 
ganglia and subsequent aperistalsis in the colon (McCallion et al. 2003; Amiel et al. 2008; Tam 
and Garcia-Barcelo 2009).  More than half of familial and sporadic cases have been shown to be 
linked to the RET locus although a small fraction of cases are also linked to the EDNRB 
pathway.  On the other hand, the core disease phenotypes of WS are sensorineuronal hearing loss 
and pigmentary disturbance, which are usually caused by the absence of NCC-derived 
melanocytes.  WS can be further divided into four subgroups based on the presence of additional 
disease traits: WS Types 1 through 4 (Tachibana et al. 2003; Baxter et al. 2004; Pingault et al. 
2010).  For example, WS Type 4 (Waardenburg-Shah syndrome) exhibits a similar megacolon 
phenotype as seen in HSCR in addition to the two WS core traits.  WS Type 4 is often caused by 
mutational defects in several genes in the EDNRB pathway, including EDNRB, EDN3, and 
SOX10 (Tachibana et al. 2003; Baxter et al. 2004; Pingault et al. 2010).  Similarly, WS Types 1 
through 3 are also linked to the genes that play significant roles in the migration and 
development of NCC, such as PAX3 for WS Type 1and 3, and MITF and SNAI2 for WS Type 2. 
In the following, the in vivo roles of Aebp2 have been investigated using a mutant mouse 
line disrupting its transcription.  Aebp2 is essential for early mouse development based on the 
lethality observed from Aebp2-mutant homozygotes.  During embryogenesis, Aebp2 is expressed 
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mainly in cells of neural crest origin.  Consistently, the heterozygotes display a set of phenotypes 
that are usually caused by defects in the migration of NCC, suggesting critical roles for Aebp2 in 
the migration and development of NCC.  The results supporting this conclusion have been 
presented and discussed in this manuscript. 
Results 
Generation of a Mutant Mouse Line Targeting Aebp2 
To characterize the in vivo functions of Aebp2, we generated a mutant mouse line with one gene 
trap ES clone (BC0681; http://www.sanger.ac.uk/PostGenomics/genetrap/).  After we established 
this mutant line, we first characterized the insertion position of the gene trap vector (!-Geo).  As 
shown in Figure 3.1A, the !-Geo vector has inserted into the 1st intron of Aebp2.  We identified 
the 5’- and 3’-side junction regions between the !-Geo vector and the surrounding genomic 
regions, which subsequently allowed us to develop a set of three primers that could be used for 
genotyping the embryos derived from the breeding of this mutant line (Figure 3.1B).  We also 
confirmed that the gene trap vector inserted into only the Aebp2 gene locus with a series of 
Southern blot experiments (Figure 3.1C).  To test the truncation of Aebp2 transcription by the !-
Geo vector, we performed qRT-PCR assays using total RNA isolated from the brains of one-day-
old neonates [wild-type (+/+) and heterozygotes (+/-)] (Figure 3.1D).  According to separate 
qRT-PCR runs measuring the expression levels of two alternative forms, the expression levels of 
Aebp2 in the heterozygote were lower (about 30 %) than those detected in the wild-type 
littermate, confirming the proper truncation of Aebp2 expression by the gene trap vector (!-


















Breeding Experiments of the Aebp2 Mutant Line 
We performed two series of breeding experiments to test potential roles of Aebp2 in normal 
development and survival of the mouse.  First, we performed the following three breeding 
experiments: male or female heterozygotes with their littermates and an intercrossing between 
two heterozygotes (Table 1).  The results revealed a slight reduction in the litter size for both 
breeding: 8 for both F(+/-) x M(+/+) and F(+/+) x M(+/-) vs. 9 for the control breeding F(+/+) x 
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M(+/+).  The ratios between the heterozygote and wild type in both breeding were very close to 
the expected mendelian raio (1:1).  In contrast, the intercrossing between two heterozygotes 
derived a much smaller litter size (6) than that of the control breeding (9).  Also, none of the 
homozygotes for the Aebp2-mutant allele were found among the offspring derived from 19 
litters, confirming the embryonic lethality associated with the Aebp2 locus.  To determine the 
exact time point of this lethality, we performed another series of intercrossing breeding 
experiments with timed-mating, which allowed us to harvest embryos at two different stages: 
10.5 and 14.5 day post coitum (dpc), but we did not obtain any homozygotes among the 
harvested embryos, suggesting that the lethality likely occurs at least before the organogenesis 
stage (Table 2).  In sum, these breeding experiments confirm an essential role for Aebp2 during 
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Spatial and Temporal Expression Patterns of Mouse Aebp2  
Since the Aebp2 locus in the mutant line has been targeted by the promoterless gene trap vector 
(!-Geo), we took advantage of this !-Geo reporter system for analyzing the temporal and spatial 
expression patterns of mouse Aebp2.  First, we performed a series of !-Gal staining with whole-
mount and cryo-sectioned embryos that had been harvested at various developmental stages 
(Figure 3.2).  In the sectioned 6.5-dpc embryos, the Aebp2 expression was detected at the 
highest levels in the embryonic ectoderm (Ect) and primitive streak (PS), and at moderate levels 
in chorion (Ch) and allantois (Al) (Figure 3.2A).  In the whole-mount embryos (9.5, 13.5, and 
14.5 dpc), the Aebp2 expression was detected in the midbrain, the branchial arches and along the 
somites (Figure 3.2A).  In the sagittal-sectioned 15.5-dpc embryos, the Aebp2 expression was 
detected in relatively high levels in tissues derived from neural crest cells, including dorsal root 
ganglia, endocrine organs, facial cartilage and bone, and the surface of intestine, heart, and lung 
(Figure, 3.2B-D).  Second, we also surveyed the sectioned tissues derived from 2-month-old 
adult mice of both genders.  The most obvious expression sites include brain and testes (data not 
shown).  These results are consistent with those from previous studies, revealing high levels of 
expression in early embryonic stages and adult brains (He et al. 1999; Kim et al. 2009).  Overall, 
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it is intriguing that Aebp2 expression was most obvious in tissues derived from the neural crest 















Visible Phenotypes of the Aebp2 Heterozygotes  
While breeding the Aebp2 mutant line, we observed the following phenotypes from the Aebp2 
heterozygotes.  First, about one quarter of the Aebp2 heterozygotes tend to show a pot-shaped 
belly, and seem to have difficulty in discharging feces.  Furthermore, when we examined the 
internal organs of these mice, some of these mice displayed enlarged, green-colored colons 
(megacolon, Figure 3.3A).  This megacolon phenotype is caused by the absence of neural crest-
derived ganglia and subsequent aperistalsis in the colon (McCallion et al. 2003; Amiel et al. 
2008; Tam and Garcia-Barcelo 2009).  Thus, the intestines harvested from the Aebp2 
heterozygotes were analyzed using the acetylcholine esterase staining method (Enomoto et al. 
1998; Carrasquillo et al. 2002).   Out of the 28 Aebp2 heterozygotes examined, 8 mice showed a 
significantly reduced density of ganglion cells in the section between the anus and cecum as 
compared to the wild-type littermates (Figure 3.3A).  Also, this megacolon phenotype seemed to 
be more pronounced among the older mice.   
Second, although we maintained this mutant strain in the 129/B6-mixed background with 
the black coat color (a/a), we observed a large fraction of the Aebp2 heterozygotes with white 
spotting at the tail tip (Figure 3.3B).  The length of the white spot area varied among the 
individual mice of the same litter ranging from 0.2 to 1.5 cm, but the lengths of the white area in 
the littermates from the intercrossing between the Aebp2 heterozygotes were longer than those 
from the crossing between the wild type and heterozygotes.  Some of the Aebp2 heterozygotes 
even showed white toes on their hind feet.  Third, a large portion of the Aebp2 heterozygotes did 
not exhibit a brisk acoustic startle response to clapping sounds, suggesting potential hearing 
defects, although this needs to be further substantiated through more physiologic and pathologic 
tests.  In addition to these three phenotypes, we also occasionally observed overgrown teeth 
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among the Aebp2 heterozygotes, but much less frequently than the white spotting on the tail tip 
(Figure 3.3C).  Overall, the three phenotypes observed from the Aebp2 heterozygotes are similar 
to those observed from Waardenburg syndrome Type 4 (WS4): megacolon, hypopigmentation, 

















Aebp2 Mutation Effects on the Expression Levels of the Disease Genes of NCC   
The HSCR and WS phenotypes observed in the Aebp2 mutant are frequently associated with 
mutations within a set of about 10 susceptible genes that are involved in the RET and EDNRB 
signaling pathways (Amiel et al. 2008; Tam and Garcia-Barcelo 2009).  Since AEBP2 is a DNA-
binding protein with NCC-specific expression, it is likely that Aebp2 may control these 
susceptible loci as a regulator, and subsequently that de-regulation of some of these genes may 
be responsible for the observed phenotypes in the Aebp2 heterozygotes.  To test this prediction, 
we measured and compared the expression levels of a set of 10 susceptible genes between the 
Aebp2 hetrozygotes and wild-type littermates (Figure 3.4).  Since the gene dosage (or 
expression levels) of these loci are critical during embryogenesis, this series of qRT-PCR 
analyses mainly used the total RNA isolated from the two groups of embryos with three different 
stages, 10.5, 14.5 and 17.5 dpc (Figure 3.4). 
For this series of qRT-PCR analyses, we first calculated the expression level of each gene 
relative to that of an internal control, !-actin, and later compared these relative values derived 
from the Aebp2 heterozygotes and wild-type littermates.  As shown in Figure 3.4, the expression 
levels of Aebp2 in the heterozygotes decreased 40-50 percent (0.5-0.6 fold) compared to those 
from the wild-type littermates, confirming the disruption of the Aebp2 transcription.  In 10.5-dpc 
embryos, all of the analyzed genes, with the exception of Mitf, showed relatively high levels of 
expression based on their Ct values ranging from 21 through 29 (Ct value of !-actin being 19).  
Most genes were down-regulated in the Aebp2 hetrozygotes: the genes with the most significant 
changes were Sox10 (0.5 fold) and Pax3 (0.5 fold).  In contrast, Snai2 showed an up-regulation 
(2 fold), and this up-regulation appears to be very significant based on its high levels of 










In 14.5-dpc embryos, the majority of the genes in the Aebp2 heterozygotes were also 
down-regulated as seen in the 10.5-dpc embryos.  The most significant down-regulation was also 
observed in Sox10 (0.5 fold).  However, the down-regulation of Pax3 became much milder in the 
14.5-dpc embryos than in the 10.5-dpc embryos.  This was also true for the up-regulation of 
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Snai2: 1.1 fold in the 14.5-dpc embryos compared to 2.0 fold in the 10.5-dpc embryos.  This 
trend was also detected in the 17.5-dpc embryos: the majority of the genes displayed very 
marginal differences in their expression levels between the Aebp2 heterozygotes and wild-type 
littermates (data not shown).  Overall, the expression analyses revealed that the majority of the 
genes involved in the migration and development of NCC are down-regulated during the 
organogenesis stage (E10.5 to14.5), and that the expression levels of one gene, Sox10, is 
significantly affected in the Aebp2 heterozygotes.          
In vivo Binding of AEBP2 and PRC2 to the Disease Loci Associated with NCC 
The in vivo binding of AEBP2 to the disease loci of HSCR and WS was further tested using 
Chromatin ImmunoPrecipitation (ChIP) experiments (Figure 3.5).  Since AEBP2 is a potential 
targeting protein for PRC2, we also tested the binding of EZH2 and the methylation on Lys27 of 
Histone 3 (H3K27me3) to these loci, which represent a key component and a functional outcome 
of PRC2, respectively.  For this series of ChIP experiments, we prepared one set of the cross-
linked chromatin isolated from the wild-type littermates of the 14.5-dpc stage (Figure 3.5).   
We selected the promoter region of each of these disease loci for this survey.  First, the majority 
of these loci except Zfhx1 were indeed bound by AEBP2 based on the detection of enrichment of 
the immunoprecipitated DNA by polyclonal AEBP2 antibodies.  This was also true for EZH2 
and H3K27me3: the majority of the loci except Zfhx1 showed the enrichment of the 
immunoprecipitated DNA by the EZH2 and H3K27me3 antibodies.  These results confirmed the 
in vivo binding of AEBP2 and PRC2 to the disease loci of HSCR and WS.  Also, the co-
occupancy by AEBP2 and PRC2 further supports that AEBP2 may be a targeting protein for 












Aebp2 Mutation Effects on the PRC2 Involvement in the Disease Genes of NCC   
Since AEBP2 is a potential targeting protein for PRC2, we further hypothesized that the changes 
observed in the expression levels of several genes may be a result of de-regulation of the PRC2-
mediated control in the Aebp2 heterozygotes (Figure 3.4).  To test this hypothesis, we 
performed another series of similar ChIP experiments as described above, and compared the 
levels of the binding of AEBP2, EZH2, and H3K27me3 to these loci between the wild type and 


























In the majority of the tested loci, the enrichment levels of the precipitated DNA by the AEBP2 
antibody were lower in the Aebp2 heterozygotes than in the wild-type embryos (Figure 3.6A).  
This is expected since the protein levels of AEBP2 should be lower in the Aebp2 heterozygotes 
than in the wild-type embryos.  This was also the case for EZH2: the enrichment levels on the 
majority of the loci were similarly lower in the Aebp2 heterozygotes (Figure 3.6B).  
Interestingly, however, the methylation levels of H3K27me3 on these loci were higher in the 
Aebp2 heterozygotes than in the wild-type embryos (Figure 3.6C).  The higher levels of the 
methylation of H3K27me3 were unexpected since the AEBP2 and EZH2 binding to these loci 
(and thus the functional involvement of PRC2) was found to be less in the Aebp2 heterozygotes 
than in the wild-type embryos.  This may indicate the possibility that the methylation level of 
H3K27me3 may not be simply proportional to the level of the PRC2 binding to any given locus, 
which has been observed in the recent studies of Jarid2, another potential targeting protein for 
PRC2 (Peng et al. 2009; Shen et al. 2009; Li et al. 2010). 
Overall, the changes in the methylation levels of H3K27me3 observed in the Aebp2 
heterozygotes supports the initial prediction that Aebp2 likely controls the genes associated with 
the migration and development of NCC through the PRC2-mediated mechanism.  Also, since the 
H3K27me3 mark is regarded as a repression signal, the increased levels of methylation of 
H3K27me3 is somewhat consistent with the reduced levels of the transcription of the genes 
associated with NCC in the Aebp2 heterozygotes (Figure 3.4).  
Discussion 
In this chapter, the in vivo roles of Aebp2 have been investigated using a mutant mouse line 
disrupting its transcription.  Aebp2 is essential for early mouse development based on the 
lethality observed from Aebp2-mutant homozygotes.  Furthermore, the half dosage of Aebp2 
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appears to be insufficient for the proper migration of some neural crest cells as the Aebp2 
heterozygotes display a set of phenotypes very similar to those from HSCR and WS.  The 
majority of the genes involved in the RET and EDNRB signaling pathways appear to be 
downstream target genes of Aebp2 and PRC2, and also changes in the expression levels and in 
the methylation levels of H3K27me3 of some of these genes are likely accountable for the 
phenotypes observed in the Aebp2 heterozygotes.  These results suggest that Aebp2 may control 
these genes through the PRC2-mediated epigenetic mechanism, and also that epigenetic 
mechanisms are likely involved in the pathogenesis of WS and HSCR.    
Genetic breeding experiments revealed embryonic lethality in the Aebp2-mutant 
homozygotes but survival of the heterozygotes to adulthood with fertility (Table 1).  The 
breeding experiments also estimated the timing of the observed lethality to be before 10.5 dpc 
(Table 2).  The exact timing and cause of this lethality remain to be further investigated, but are 
likely similar to those observed from the other components of PRC2, such as Ezh2, Eed, and 
Suz12 (Faust et al. 1995; O’Carroll et al. 2001; Pasini et al. 2004).  The null mutants for these 
genes fail to form the three germ layers after implantation, suggesting essential roles for these 
genes in the lineage specification of the germ layers.  Given the tight interactions between Aebp2 
and PRC2 (Schuettengruber and Cavalli 2009), we predict that Aebp2 plays critical roles in 
establishing the three germ layers, and thus the observed lethality in the Aebp2-null mutants may 
be an outcome of the failure of formation of the three germ layers during the gastrulation stage.  
The evolutionary conservation of Aebp2 is noteworthy: its homologues are present in species 
ranging from flying insects to humans (Kim et al. 2009).  Given this evolutionary conservation, 
Aebp2 is likely involved in the regulation of a large number of genes and pathways, and thus its 
depletion should be detrimental for the survival of the embryos.  Overall, the embryonic lethality 
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observed from the Aebp2-null mutants suggests an essential role for this PcG gene during early 
embryogenesis.          
According to the results derived from the previous studies, the expression patterns of 
Aebp2 are considered to be ubiquitous (He et al. 1999; Kim et al. 2009).  However, one unique 
observation from this study is the detection of very high levels of Aebp2 expression in neural 
crest cells during embryogenesis (Figure 3.2).  This unexpected observation appears to be 
somewhat consistent with Aebp2’s functional connection with PRC2.  The migratory NCC is 
regarded as a multipotent stem cell since it gives rise to so many different cell types in the major 
organs of adult vertebrates (Stemple and Anderson 1992; Sauka-Spengler and Bronner-Fraser 
2008a, 2008b).  Stem cells are characterized by two core features, multipotency and self-renewal 
without differentiation, and these features are usually maintained by epigenetic mechanisms, 
especially by PRC2 (Boyer et al. 2006; Lee et al. 2006; Chen et al. 2008; Jaenisch and Young 
2008).  Migratory NCC likely employs PRC2 to maintain these properties during embryonic 
development.  Therefore, Aebp2 expression in NCC may be required to provide these two 
properties to this stem cell population.  If this is the case, the other components of PRC2 should 
also be highly expressed in NCC, as is Aebp2.  This will require further testing in the near future. 
Although the homozygotes for the Aebp2-knockin allele are lethal, the heterozygotes are 
viable, fertile, and display intriguing phenotypes such as enlarged colon and hypopigmentation 
(Figure 3.3).  Since the Aebp2-knockin allele disrupts the transcription of Aebp2, this mutation 
is regarded as a loss-of-function-type mutation.  The phenotypes generated by the Aebp2 
mutation are also regarded as dominant traits based on their detection in heterozygotes.  
Therefore, the dominance of these phenotypes is likely an outcome of haploinsufficiency, 
meaning the reduced dosage of Aebp2 is responsible for the observed phenotypes.  Similar 
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situations also occur in human patients with Hirschsprung’s disease (HSCR) and Waardenburg 
Syndrome (WS).  In most cases of these disorders, mutational defects are found in the genes 
involved in the migration process of NCC, RET and EDNRB signaling pathways (Amiel et al. 
2008; Tam and Garcia-Barcelo 2009).  The disease alleles are also loss-of-function-type 
mutations, and inherited as autosomal dominant traits.  Therefore, haploinsufficiency is also the 
primary mode for the dominant phenotypes by these disease alleles.  Overall, there are many 
similarities between the Aebp2-knockin allele and the disease alleles of HSCR and WS.  In 
particular, the similar mode of the phenotype dominance, haploinsufficiency, may indicate that 
the migration process of NCC is very susceptible to changes in the gene dosage of the 
participating loci.  Thus, it is likely that the gene dosage of Aebp2 is very critical for the proper 
migration and development of NCC. 
As a DNA-binding protein, AEBP2 most likely exerts its in vivo roles through its 
unknown downstream genes.  As predicted, ChIP experiments confirmed that AEBP2 indeed 
binds to the majority of the genes involved in the development and migration of NCC during 
embryogenesis (Figure 3.5).  Expression analyses further confirmed changes in the expression 
levels of some of these genes by the half dosage of Aebp2 (Figure 3.4).  In particular, one gene 
(Sox10) is consistently down-regulated in the Aebp2 heterozygotes.  This is analogous to the 
reduced gene dosage of SOX10 frequently linked to WS Type 4 in humans.  Also, the phenotypes 
observed in the Aebp2 heterozygotes are seen in human patients with WS Type 4 (Pingault et al. 
2010).  It is possible that Aebp2 is responsible for the observed phenotypes via Sox10.  However, 
we cannot rule out the possibility that the effects of the Aebp2 mutation might occur more 
globally and at much earlier stages than described.  If this is the case, the observed phenotypes 
should not be accounted for by the mis-expression of a single gene.  This is evidenced by the 
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observation that other genes involved in the migration of NCC are also affected in the Aebp2 
heterozygotes.  These possibilities require further investigation.  It will be very interesting to 
determine if the changes in the Sox10 expression are primarily responsible for the phenotypes 
observed in the Aebp2 heterozygotes.   
HSCR and WS demonstrate incomplete penetrance mainly due to their oligogenic nature 
and other non-genetic factors involved in their pathogenesis (McCallion et al. 2003; Owens et al. 
2005; Amiel et al. 2008; Tam and Garcia-Barcelo 2009).  Identification of Aebp2 as a potential 
disease locus for these disorders is an intriguing possibility.  If, as our data suggest, Aebp2 exerts 
its roles through PRC2, it may require optimal concentrations of the cellular enzymes and 
substrates necessary for histone modification reactions.  The outcome of these reactions may 
vary depending on the nutritional status and environmental conditions of developing embryos, 
resulting in different levels of histone modification among individuals.  This type of inter-
individual differences, also known as epigenetic variations, may be a major factor contributing to 
phenotypic variations (e.g. incomplete penetrance) (Jirtle and Skinner 2007; Bollati and 
Baccarelli 2010).  Unfortunately, epigenetic variations have not been discernible by traditional 
genetic studies, which rely on genetic variations.  We predict that this is the case for both HSCR 
and WS since the majority of the associated disease genes are modified by PRC2 (Figure 3.5).  
It is possible that different levels of histone modifications of the disease alleles are accountable 
for the phenotypic variations (incomplete penetrance) observed for HSCR and WS.  In sum, 
characterizing Aebp2 as an epigenetic regulator may provide a new and exciting direction for the 




Materials and methods 
Generation and Breeding of the Aebp2 Knockin Mutant Mice 
One gene trap clone, BC0681 (strain 129/OlaHsd) from SIGTR (Sanger Institute Gene Trap 
Resource, http://www.sanger.ac.uk/PostGenomics/genetrap/), was injected into mouse 
blastocysts to generate chimeric mice.  Injection of these cells into C57BL/6 blastocysts was 
performed at The Darwin Transgenic Mouse Core Facility (Baylor College of Medicine, 
Houston, TX, USA).  The male chimeric mice were bred with female C57BL/6 mice, and the 
following F1 offspring with agouti coat color was further genotyped to confirm the germline 
transmission of the Aebp2-knockin allele.  This initial genotyping was performed with PCR 
using a primer set targeting the NeoR coding region of the gene trap vector (pGT2lxr).  All the 
experiments related to mice were performed in accordance with National Institutes of Health 
guidelines for care and use of animals. 
Southern Blot and Genotyping by PCR  
Genomic DNA was purified from the spleens of the wild-type and Aebp2 heterozygote mice 
with DNAzol (Invitrogen).  Ten µg of these genomic DNA was used for each of EcoRV and SacI 
digestion reactions, separated on a 0.8% agarose gel, and finally transferred onto Hybond nylon 
membranes (Amersham) by capillary blotting.  Membranes were hybridized with a 32P-labeled 
probe corresponding the 1st intron region of Aebp2 (Figure 3.1). 
The mice were genotyped by PCR using the following three primers: F1, 5-
ACCAGGGTTGAAACAGAAGAACTCTG-3; R1, 5-AGGTGCTGCACTCACACTCCCA-3; 
R2, 5-AACGGTAGGATCCCAAGGGCAGTA-3.  The 570-bp product generated by F1 and R1 
primers is amplified from the endogenous allele of Aebp2, thus representing the wild-type allele.  
In contrast, since the R2 primer is derived from the gene trap vector, the 304-bp product by F1 
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and R2 represents the Aebp2 knockin allele.  PCR conditions were 33 cycles at 95°C for 30 
seconds, 60°C for 30 seconds, and 72°C for 30 seconds.   
The genders of neonatal mice and embryos were determined by PCR using the primer set 
of the mouse Sry gene under the same PCR conditions described above; mSry-F (5-
GTCCCGTGGTGAGAGGCACAAG-3) and mSry-R (5-GCAGCTCTACTCCAGTCTTGCC-
3).  To prepare genomic DNA from clipped tails or ears, each tissue was incubated overnight at 
55°C in the lysis buffer (0.1 M Tris-Cl, 5 mM EDTA, 0.2% SDS, 0.2 M NaCl, pH 8.0, 20 µg/ml 
Proteinase K).  One µl of the lysed extract was first diluted with 30 µl of TE, and one µl of the 
diluted extract was finally used for each PCR amplification. 
!-Galactosidase Staining 
Pregnant dams with time-mating were sacrificed at various stages during embryonic 
development.  The embryos were fixed overnight in fixing solution (0.2% paraformaldehyde, 0.1 
M PIPES buffer pH 6.9, 2 mM MgCl2, 5 mM EGTA).  The fixed embryos were then cryo-
protected in PBS buffer containing 30% sucrose and 2 mM MgCl2 at 4°C overnight, or until the 
embryos sank to the bottom.  The embryos were further embedded in OCT and frozen at -80°C.  
The embedded embryos were sectioned on a crytome (Leica) to 50 micron thickness and placed 
onto poly-L-lysine coated slides.  The sections were further immobilized in the fixing solution 
for 10 minutes.  After rinsing in PBS for 10 minutes, they were placed in detergent rise solution 
(2 mM MgCl2, 0.01% sodium deoxycholate, 0.02% NP-40 in PBS) for 10 minutes.  The sections 
were then placed at 37°C overnight in the staining solution (2mM MgCl2, 0.01% sodium 
deoxycholate, 0.02% NP-40, 5mM potassium ferricyanide, 5mM potassium ferrocyanide) 
containing 1 mg/ml of bromo-chloro-indolyl-galactopyranoside (X-gal).  For better contrast, the 
heart and thymus tissue sections were counterstained with eosin Y. 
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For whole-mount staining, embryos were fixed in 4% paraformaldehyde for 2 hours and 
stained overnight at 37°C in the staining solution containing 1 mg/ml of X-gal.  Tissue sections 
and whole-mount embryos were visualized using a dissecting stereo light microscope (Leica 
MZ75).  Images were captured with a digital camera (Model #4.2 Color Mosaic, Diagnostic 
Instruments Inc.).  
Acetylcholinesterase Staining 
The intestines from one-month old mice were harvested and fixed in 4% paraformaldhyde for 1 
hour at 4°C.  After incubation in saturated sodium sulfate overnight at 4°C, the intestines were 
further incubated for 4 hours in staining buffer (0.2 mM ethopropazine HCl, 4 mM 
acetylthiocholine iodide, 10 mM glycine, 2 mM cupric sulfate, and 65 mM sodium acetate, pH 
5.5).  Lastly, the acetylcholinesterase activity was detected by incubating the intestines in 1.25% 
sodium sulfide, pH 6, for 1.5 minutes.   
Quantitative Reverse Transcription PCR and Data Analysis 
Total RNA was extracted from tissues using Trizol (Invitrogen).  Reverse transcription was 
performed using the M-MLV kit (Invitrogen).  Quantitative real time PCR was performed with 
the iQ SYBR green supermix (Thermo Scientific) using the icycler iQ multicolor real-time 
detection system (Bio-Rad).  All qRT-PCRs were carried out for 40 cycles under the standard 
PCR conditions.  We analyzed the results of qRT-PCR based on the threshold  (Ct) value.  A " 
Ct was first calculated through subtracting the average Ct value of an internal control (!-actin) 
from the average Ct value of a given target gene.  Later, the " " Ct was calculated through 
subtracting the " Ct value of the target gene in the Aebp2 heterozygote from the " Ct value of 
the same gene in the wild-type littermate.  Fold differences were determined by raising 2 to the " 
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" Ct powers (Winer et al. 1999).  Information regarding individual primer sequences and PCR 
conditions is available upon request (or see http://jookimlab.lsu.edu/?q=node/36). 
Chromatin ImmunoPrecipitation (ChIP) Experiments 
Chromatin immunoprecipitations were performed according to the protocol provided by Upstate 
Biotechnology (Upstate Biotech.) with some modification as described previously (Kim et al. 
2003).  Briefly, mouse embryos at various stages were harvested and homogenized in 10 ml 
PBS.  The samples were treated with formaldehyde to the final concentration of 1% and 
incubated at 37°C for 10 minutes.  Treated samples were sheared by sonication and 
immunoprecipiated with anti-AEBP2 (Cat. No. 11232-2-AP, ProteinTech Group), EZH2 (Cat. 
No. ab3748, Abcam), and H3K27me3 (Cat. No. 07-449, Upstate Biotech.) antibodies.  
Precipitated DNA and protein complexes were reverse cross-linked and purified through 
phenol/chloroform extraction.  Purified DNA was used as template DNA for PCR amplification.  
PCR reactions were carried out for 40 cycles using standard PCR conditions.  The resulting PCR 
products were run on 1.6% agarose gels containing ethidium bromide.  All ChIP assays were 
performed independently at least three times.  The oligonucleotide sequences used for this study 
are available upon request (or see http://jookimlab.lsu.edu/?q=node/36).  
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Of approximately 25,000 genes in the human genome, 10% encode transcription factors 
(Babu et al., 2004).  Those that are fundamental to organism survival are evolutionarily well 
conserved, while those that gained their function in adaptation to the environment are species-
specific (Edger and Pires, 2009).  Genomic studies can reveal the history of a gene and generate 
new theories based on their evolutionary conservation.   
In this dissertation, I have characterized the transcription factor AEBP2, a highly 
conserved DNA-binding protein that may target the PRC2 complex.  Our data revealed that 
Aebp2 is predominantly expressed in neural crest cells. Thus, Aebp2 may regulate neural crest 
development through the PcG-mediated machinery.   
Chapter two discusses the evolutionary conservation, gene structure and DNA binding 
properties of Aebp2.  Genomic studies showed that the zinc finger and the basic domains are the 
most evolutionarily conserved domains.  In addition, our studies identified two alternative 
promoters of Aebp2 that can generate two separate protein products: one 31kDa protein and one 
51kDa protein.  Many genes in our genome have been reported to contain alternative promoters 
(Kimura et al., 2006).  Characterizing these two promoters would be important for understanding 
the function of Aebp2.  Future experiments will characterize these promoters by: performing 
reporter assays with the two alternative promoters; and generating conditional knockout mice 
with deletion of each promoter.  Most likely, the two Aebp2 isoforms will have different effects 
on their downstream genes since their interacting protein partners will vary.   
For the DNA binding studies of Aebp2, we performed a series of EMSA and ChIP-
cloning experiments.  The results of these experiments identified the consensus DNA binding 
motif CTT(N)15-23cagGCC.  In addition, ChIP assays demonstrated that Aebp2 co-occupies many 
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target loci with PRC2.  Thus, we propose Aebp2 as a new mammalian targeting protein for 
PRC2 to specific regulatory regions.   
Chapter three addresses the in vivo function of Aebp2.  Breeding experiments of Aebp2 
knockin mice revealed that Aebp2 is critical for proper embryonic development.  Aebp2 
homozygous mutants were lethal at an early stage, presumably soon after gastrulation.  It has 
been reported that PcG proteins may be involved in cell lineage determination (Kerpolla, 2009).  
If this were the case, proper cell differentiation cannot occur in the Aebp2 mutant mice.   Since 
transcription factors are usually expressed in a highly restricted manner, spatially and temporally 
characterizing the expression sites of the protein is critical to discern its function.  The (-gal 
staining system in the Aebp2 knockin mice allowed us to visualize the expression sites of Aebp2.  
Although Aebp2 expression was seen throughout embryonic development, high levels of Aebp2 
expression were observed in the neural crest cells of E15.5 embryos.  Consistently, some adult 
Aebp2 heterozygotes showed megacolon and white tail tip phenotypes, which are caused 
typically by defects in neural crest cell development or migration.  We also examined the 
expression of transcription factors, growth factors and receptors known to be critical for proper 
neural crest development in wild-type and mutant embryos to understand the molecular effect of 
Aebp2 haploinsufficiency in neural crest development.  ChIP assays confirmed that many of 
these genes were indeed bound by both Aebp2, Ezh2 and contained H3K27me3 in their promoter 
regions.  In addition, when we compared the binding enrichment of Aebp2 and Ezh2 to the 
promoter regions of the neural crest genes in wild-type and mutant mice, both Aebp2 and Ezh2 
binding were reduced in the Aebp2 heterozygous mutant mice.  These results support our 
hypothesis that Aebp2 is responsible for recruiting the PRC2 complex to the genes that regulate 
neural crest development.   
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Interestingly, however, the enrichment of H3K27me3 was increased in the Aebp2 
heterozygotes compared to the wild-type mice.  The elevation of H3K27me3 levels seems to 
correlate with the reduced expression of the downstream genes we observed in the Aebp2 mutant 
mice.  However, the increase in H3K27me3 in Aebp2 mutant mice was unexpected.  A model 
summarizing our results is in Figure 5.1.    
 
 
Figure 5.1. A model describing the effect of Aebp2 heterozygousity on the PRC2 targeting 
and the subsequent effect on its downstream genes.  Figure 5.1A illustrates the binding of 
PRC2 components to the promoter region of PcG target genes in wild type mice.  The histone 
tails are indicated in a grey protruding away from the nucleosomes (which are indicated in white 
circles with DNA wrapped around it) and the H3K27me3 are indicated in red.  An ideal level of 
transcription exists when all the components are properly bound.  If Aebp2 is downregulated (as 
in the Aebp2 heterozygous mice), other PRC2 components cannot bind to their targeting region 
efficiently.  As a result, other factors such as Ezh1 or PRC1 may compete against the PRC2 
complex and induce ectopic histone methylation on H3K27 and the downstream genes are 
further repressed (Figure 5.1B).   
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Previous biochemical studies have demonstrated that Ezh2 is the enzyme responsible for 
trimethylation of the lysine 27 in histone H3 (Cao et al., 2004).  If the recruitment of Ezh2 is 
reduced due to insufficient levels of Aebp2, there should also be reduced levels of H3K27me3.  
Then why do we observe more histone methylation on H3K27?  It has recently been suggested 
that Jarid2 potentially targets the PRC2 complex.  This protein belongs to the family of the 
Jumonji proteins, which are responsible for histone demethylation.  However, the enzymatic 
domain in the Jarid2 protein is missing, so that it does not exhibit any histone demethylation 
properties (Takeuchi et al., 2006).  According to the four independent experiments of Jarid2, two 
groups also observed that the enrichment of H3K27me3 increased when the core PRC2 proteins 
recruitment was reduced (Peng et al., 2009; Shen et al., 2009).  These observations are consistent 
with our data demonstrating increased H3K27me3.  
I propose three possibilities for the increased levels of H3K27me3 in the Aebp2 
heterozygote mice.  First, PRC1 may induce the H3K27me3 machinery when PRC2 cannot 
fulfill its function, and this may lead to over-methylation of H3K27 in the Aebp2 heterozygous 
mutant cells (Figure 5.1B).  As a result, cell properties that arise may be abnormal.  Although 
the H3K27me3 mark, an outcome of PRC2, is a recruiting signal for PRC1 (Wang et al., 2004; 
Fischle et al., 2003; Min et al., 2003), some studies have shown that PRC1 can bind to PcG 
target genes independently of PRC2 (Schoeftner et al., 2006).  For instance, in cancer cells the 
PcG target genes are often methylated in their DNA (Iacobuzio-Donahue, 2009).  Lack of critical 
transcription factors such as Aebp2 could trigger compensatory histone methylation and also 
DNA methylation.  Although Ezh2 is the histone methyltransferase that methylates H3K27, the 
correlation between PRC2 and H3K27me3 may not be as simple as we imagine.  Secondly, 
Ezh1, an isoform of Ezh2, has also been shown to methylate H3K27 when Ezh2 is not present 
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(Shen et al, 2008).  Factors responsible for recruiting Ezh1 may be favored when the targeting 
proteins for PRC2 are missing.  This could also lead to compensatory histone methylation on 
H3K27 (Figure 5.1B).  Thirdly, reduced levels of Aebp2 and Ezh2 could cause delay in the 
removal of H3K27me3 marks when the neural crest genes need to be activated.  In this case, 
improper demethylation of H3K27me3 by trithorax groups (trxG) factors such as Jmjd3 and Utx, 
might have caused the reduced expression of neural crest genes.  Further investigation is required 
to explain our unexpected experimental results.  Nevertheless, it is most likely that Aebp2 is 
responsible for targeting the PRC2 complex to the genes that are important in neural crest cell 
development. 
In the near future, we plan to test potential roles of PRC2 in neural crest development 
using Ezh2 conditional knockout mice.  We should be able to knockout Ezh2 in the neural crest 
cell lineage using Wnt1-cre, which is neural crest-specific.  If, as we hypothesized, the defects in 
the neural crest cells observed in Aebp2 heterozygotes are caused by the PRC2 mediated 
mechanism, similar phenotypes should also be visible in the knockout mice of the PRC2 
proteins.  It is possible that megacolon phenotypes will arise in these conditional knockout mice.  
We will also generate conditional knockout mouse lines for Aebp2.  These conditional knockout 
lines may allow us to ascertain when and where Aebp2 is critical for neural crest cell 
development.  
 Many diseases are associated with defects in neural crest cells.  Because of its 
multipotent nature, it is an interesting cell lineage to study.  Our studies are among the first to 
merge the field of neural crest cell development and the field of epigenetics.  This approach may 
give us a better understanding of a variety of cell types.  I believe the study of the epigenetic 
properties of neural crest cells deserves as much attention as has been given to the study of the 
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epigenetic properties of cancer and stem cells.  In fact, it has been suggested that adult stem cells 
might be a derivative of neural crest cells (Slack, 2007).  Robert Weinberg, the noted cancer 
biologist, claimed that metastasizing cancer cells resemble neural crest cells migrating 
throughout our body.  Many of the transcription factors important in cancer metastasis, such as 
Twist and Snail, are also critical transcription factors for neural crest cell migration (Weinberg, 
2007; Yang et al., 2006).  Most importantly, neural crest cells, cancer cells, and stem cells all 
seem to be prone to epigenetic changes.  Thus, it would be worthwhile to understand and 
compare the epigenetic machinery behind these cell types.  
This dissertation chronicles the function of an evolutionarily well-conserved gene, Aebp2.  
It illustrates how we first characterized a gene from an evolutionary perspective and then 
determined its molecular function in vitro and in vivo.  Our studies not only reveal a new 
function of an uncharacterized gene, but also bring new insight into the field of developmental 
biology, genetics, and epigenetics.     
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